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1. Summary 
The control of mRNA translation mediated by RNA#binding proteins (RBPs) is a key player in 
modulating gene expression. In S. cerevisiae, the multi#KH domain protein Scp160 associates 
with a large number of mRNAs and is present on membrane#bound and, to a lesser extent, 
cytosolic polysomes. Its binding site on the ribosome is close to the mRNA exit tunnel and in 
vicinity to Asc1, which constitutes a binding platform for signaling molecules. The present study 
focused on the closer characterization of the Scp160#ribosome interaction and on the suggested 
function of Scp160 in modulating the translation of specific target mRNAs.  
Using affinity purifications, the partial RNA#dependence of the Scp160#ribosome association was 
confirmed. In contrast to published results, ribosome association was found to be only slightly 
reduced but not abolished in the absence of Asc1 or the last two KH domains. Furthermore, the 
putative elongation regulator Stm1 was identified as a co#purifier of Scp160. In subcellular 
fractionation experiments, RNA#binding mutants of Scp160 were present in the ribosome#free 
cytosolic fraction and therefore partially deficient in ribosome association and/or mRNP 
formation. However, no physiological conditions were found that equally induce a shift of 
wildtype Scp160 towards the cytosolic fraction. 
Within the scope of a translational profiling approach, microarray analyses of RNA isolated from 
sucrose density gradient fractions were performed and led to the identification of a set of 
mRNAs that shift their position within the gradients upon Scp160 depletion, indicating changes 
in their translation rates. Consistent with the membrane localization of Scp160, transcripts 
encoding secreted proteins were significantly enriched. Using immunoprecipitation and 
subsequent quantitative real#time PCR (qRT#PCR), the interaction of Scp160 with a subgroup of 
the identified targets was confirmed and it was shown that their binding is dependent on the 
conserved GXXG motifs in the two C#terminal KH domains of Scp160. Furthermore, data were 
obtained indicating that Scp160 can act as a translational activator on some of its target mRNAs, 
probably on the level of translation elongation. Finally, first evidence was provided that the 
translational misregulation of specific target transcripts may be involved in the polyploidization 
that is a hallmark of Scp160#deprived cells. 
In summary, these data substantiate the assumption that Scp160 is involved in translational 
regulation of a specific, functionally related subset of mRNAs. This finding is in good accordance 
with the emerging view that RBPs co#regulate multiple transcripts in order to allow faster 
adaptation to environmental changes. 
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2. Introduction 
2.1. The mRNA lifecycle is coordinated by RNAbinding proteins 
On the post#transcriptional level, RNA binding proteins (RBPs) represent what transcription 
factors are on the level of transcription – they form a complex, multi#layered regulatory network 
that tightly controls all stages of the RNA lifecycle. In this section, a brief overview of the 
numerous processes that determine the fate of an mRNA in the budding yeast S. cerevisiae will be 
given, impressively demonstrating the prominent position of RBPs in the control of gene 
expression. 
In the nucleus, ribonucleoprotein complexes, or short RNPs, start to form by the association of 
specific nuclear RBPs with nascent mRNAs even before transcription is completed (see Fig. 1). 
For example, the conserved four#protein complex THO associates with actively transcribed genes 
(Strasser et al., 2002; Abruzzi et al., 2004) in order to prevent the formation of RNA/DNA 
hybrids that promote hyperrecombination and transcriptional impairment. THO associates with 
Yra1, Sub2 and SR(serine/arginine#rich)#like proteins to form the TREX (TRanscription/EX#
port) complex which is involved in nuclear export of the nascent mRNP (Strasser et al., 2002). 
Interestingly, some of the factors that promote mRNA export are also involved in pre#mRNA 
splicing, for example Npl3 (Kress et al., 2008) and Sub2 (Zhang & Green, 2001). Other RBPs are 
required for co#transcriptional RNA processing, including the addition of the 7#methylguanosine 
(7mG) cap to the 5' end of the nascent transcript which protects it from degradation (Shatkin & 
Manley, 2000). Co#transcriptional events also include 3' end cleavage immediately downstream of 
the polyadenylation site in the 3'#untranslated region (UTR) (Zhao et al., 1999), leading to the 
release of the nascent RNA from the transcription complex. Subsequently, the poly(A) tail is 
added by a poly(A) polymerase and bound by the nuclear poly(A)#binding protein Nab2 (Mangus 
et al., 2003). By its interaction with the nuclear pore#associated protein Mlp1, Nab2 promotes 
export of mature mRNAs (Fasken et al., 2008). Mlp1 is in addition involved in the nuclear 
retention of unspliced transcripts (Galy et al., 2004). In general, mRNA processing in the nucleus 
underlies strict quality control mechanisms, leading to the degradation of aberrant transcripts that 
are produced when mRNP assembly is impaired (reviewed in Fasken & Corbett, 2009). Correctly 
processed and packaged, mRNPs are exported through nuclear pore complexes (NPCs), which is 
facilitated by the interaction of the Mex67/Mtr2 heterodimer with nucleoporins (Braun et al., 
2002). At the NPC cytoplasmic face, the DEAD#box RNA helicase Dbp5 assists in remodeling 
the mRNP, e.g. by removing Mex67/Mtr2 (Lund & Guthrie, 2005) and Pab2 (Tran et al., 2007), 
and thus prevents mRNPs from returning to the nucleus (Stewart, 2007).  
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Once in the cytoplasm, many mRNAs immediately enter the translationally active pool. The 
nuclear cap#binding complex formed by CBC20 and CBC80 is replaced by eIF4E, the major 
cytoplasmic cap#binding protein, and nuclear Nab2 is exchanged for Pab1, the cytoplasmic 
poly(A)#binding protein (Mangus et al., 2003). Interactions between Pab1, translation initiation 
factor eIF4G and cap#binding protein eIF4E induce the translation#competent "closed loop" 
conformation of the mRNA (Wells et al., 1998) that promotes ribosomal 40S subunit recruitment 
and therefore translation initiation (see section 2.2.; Tarun et al., 1997).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. The mRNA lifecycle is determined by combinatorial action of a plethora of RBPs. In the 
nucleus, pre#mRNA is processed in a co# and posttranscriptional manner by 5' end capping, splicing if 
required, 3' cleavage and polyadenylation. During these processes, quality control is exerted by the nuclear 
exosome. Correctly assembled mRNPs are exported through the nuclear pores and, in some cases, 
transported to specific subcellular regions. Translation of the transcripts often underlies control 
mechanisms. Eventually, mRNAs are degraded either through the normal decay pathway or through 
pathways specific for the removal of aberrant transcripts (figure from McKee & Silver, 2007). 
 
However, translation of a large number of mRNAs is known to be spatially restricted. For 
example, one#tenth of randomly selected mRNAs of the Drosophila oocyte are specifically 
localized to its anterior pole (Dubowy & Macdonald, 1998), and in mammalian neurons, 
approximately 400 mRNAs are targeted to the dendrites (Eberwine et al., 2001). In many cases, it 
is known that the localized transcript is held in a translationally quiescent state upon nuclear 
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export to prevent ectopic expression (Huang & Richter, 2004). Localization of specific transcripts 
is dependent on "zipcodes" that are usually found in the 3' or 5' UTRs and that are recognized by 
RBPs that link the mRNA to the localization machinery (Paquin & Chartrand, 2008).  
mRNAs have limited lifetimes, and regulation of their controlled degradation is another 
important mechanism in the modulation of gene expression. In most cases, degradation is 
induced by shortening of the poly(A) tail, which leads to the removal of the 5' cap structure 
(decapping) and thereby exposes the transcript to digestion by a 5'#3'#exonuclease (Parker & 
Song, 2004). Variations on this theme occur in nonsense#mediated decay (NMD) and nonstop 
decay (NSD) pathways, in which 3'#5'#degradation of aberrant mRNAs by the exosome plays an 
important role (Schmid & Jensen, 2008). mRNA degradation is believed to take place in  
P#bodies, cytoplasmic foci that contain the general repression/decay machinery (Parker & Sheth, 
2007). P#bodies may not only serve degradation, but can also be used to store mRNAs for a 
subsequent return to the translation cycle (Brengues et al., 2005). 
This overview illustrates that mRNAs are subject to diverse regulatory activities exerted by 
different classes of RBPs. Many of these control mechanisms rely on the combinatorial action of 
several factors, adding an additional layer of complexity which ensures that each individual 
transcript is appropriately regulated (Hogan et al., 2008). Taken together, this explains why there 
is wide variability in the degree to which mRNA and protein abundances correlate (Moore, 2005), 
and much more research will be required to obtain an exhaustive picture of the mechanisms that 
are involved in post#transcriptional control. 
 
2.2. A glimpse of translation 
Before going into details of translational control mechanisms, this section intends to give a short 
overview about eukaryotic translation. The translation process can be subdivided into three 
stages: initiation, elongation and termination, all of which require a specific subset of accessory 
factors (refer to Fig. 2). 
The first step of initiation is the assembly of the ternary complex consisting of methionine#loaded 
initiator tRNA and GTP#bound eIF2. Together with initiation factors eIF3, eIF5, eIF1 and 
eIF1A, the ternary complex associates with the 40S small ribosomal subunit to form the 43S pre#
initiation complex. On the side of the mRNA, initiation requires the association of the eIF4F 
complex with the cap structure at the 5' end of the transcript. The eIF4F complex is composed 
of the cap#binding factor eIF4E, the scaffolding protein eIF4G, and the RNA helicase eIF4A, 
whose activity is stimulated by its co#factor eIF4B (Rozen et al., 1990). Mediated by the 
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Fig. 2. A schematic view of eukaryotic translation. The translation process can be subdivided into 
three steps: initiation, elongation and termination. During initiation, the ternary complex binds to the 40S 
subunit and forms the 43S pre#initiation complex, which then associates with the mRNA. This 48S pre#
initiation complex scans the transcript for the initiator AUG, where the 60S ribosomal subunit joins and 
elongation begins. Upon recognition of a stop codon, translation is terminated and the polypeptide chain 
released. For details, see text. Eukaryotic initiation factors (eIFs) are depicted as colored, numbered 
shapes; some eIFs have been omitted for simplicity. PABP refers to poly(A) binding protein;  
Pi – pyrophosphate (figure adapted from Gebauer & Hentze, 2004). 
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interaction between initiation factors eIF4G and eIF3, the ternary complex is loaded onto the 
mRNA whereupon it is referred to as the 48S pre#initiation complex. Assisted by the initiation 
factors eIF1, eIF1A and the helicase DHX29, the 48S complex scans the transcript for the AUG 
initiation codon where it is joined by the 60S large ribosomal subunit and starts translation 
elongation. For an extensive review on translation initiation, see Preiss and Hentze (2003). 
As opposed to the large number of accessory factors that are required for initiation, only three 
factors are needed for polypeptide elongation in fungi: eEF1A, eEF2 and eEF3. eEF1A is 
responsible for the delivery of aminoacyl tRNAs to the ribosome, whereas eEF2 promotes the 
GTP#dependent translocation of the nascent protein chain from the A#site to the P#site (Taylor 
DJ, 2007). In contrast to eEF1A and eEF2, the ATPase eEF3 is only present in fungi, where it is 
essential for the binding of the ternary complex to the ribosomal A#site and is thought to 
facilitate the clearance of deacyl#tRNA from the E#site (Andersen et al., 2006). 
The release factor eRF1 mediates termination by recognition of one of the three possible stop 
codons and subsequent binding to the ribosome in place of a tRNA. Together with association of 
eRF3, this stimulates the hydrolysis of GTP and the release of the peptide chain from the 
ribosome (reviewed by Mugnier & Tuite, 1999). 
 
2.3. Don't get lost in translation – translational control 
Translation is dependent on a sophisticated cellular machinery and is a highly energy#consuming 
process. A rapidly growing yeast cell, for example, contains nearly 200 000 ribosomes that occupy 
as much as 30#40% of the cytoplasmic volume (Warner, 1999). In fast growing E. coli cells,  
30#50% of the energy gained from nutrient uptake is consumed by protein synthesis (Meisenberg 
G, 1998). Not to tightly monitor and regulate the translation process would therefore be 
detrimental to the cell, and indeed, control mechanisms have been found to act on virtually every 
level of translation. However, initiation is the step that is targeted by the vast majority of those 
mechanisms (Jackson et al., 2010). 
Two general modes of translational regulation exist: First, global control which mainly occurs by 
the modification of translation initiation factors and thus affects translation of most transcripts 
(see section 2.3.1.), and second, target#specific control that is mediated by regulatory proteins 
 recognizing specific structural features that are usually present in the UTRs (refer to section 
2.3.2.; Gebauer & Hentze, 2004).  
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2.3.1. Global control of translation 
Global translational regulation is for example mediated by various stress conditions such as 
nutrient depletion, heat shock or high osmolarity. Besides regulation at the transcriptional level, 
the elicited stress response generally involves translational repression of the majority of mRNAs. 
However, some transcripts that encode stress#relevant proteins are preferentially translated under 
these a priori repressing conditions. Taken together, the combined transriptional and translational 
response enables the cell to adapt to the stress condition (Smirnova et al., 2005; Hinnebusch, 
2005). 
One of the best#characterized mechanisms of global translation repression is based on 
phosphorylation of eukaryotic initiation factor 2 (eIF2) (reviewed in Hinnebusch, 2005). 
Together with methionine#loaded initiator tRNA, GTP#bound eIF2 is part of the ternary 
complex that associates with the small ribosomal subunit to form the 43S pre#initiation complex 
(see Fig. 2). When the startcodon is recognized, GTP is hydrolyzed, leaving eIF2 in its GDP#
bound form. To reactivate the ternary complex, GDP has to be exchanged for GTP which is 
mediated by eIF2B. This reaction is repressed when the three#subunit complex eIF2 is 
phosphorylated at a specific serine (Ser51) of its alpha subunit (eIF2α); furthermore, the 
dissociation of phosphorylated eIF2 from eIF2B is blocked, so that eIF2B is sequestered  
(Fig. 3). The resulting reduction in the amount of active ternary complexes efficiently represses 
general translation initiation. In yeast, Gcn2 (general control non#derepressible 2) is the only 
kinase known to phosphorylate eIF2α. Gcn2 activity is stimulated by uncharged tRNAs that 
accumulate during environmental stresses such as high salinity (Goossens et al., 2001), oxidizing 
conditions (Mascarenhas et al., 2008), nutrient starvation (Hinnebusch, 2005), or exposure to 
rapamycin (Cherkasova & Hinnebusch, 2003). 
Interestingly, the transcription#factor encoding GCN4 mRNA is preferably translated during 
these conditions due to a complex mechanism involving regulatory upstream ORFs (uORFs) 
(reviewed in Hinnebusch, 2005). Data from a recent large#scale study suggest that GCN4 is not 
the only mRNA escaping eIF2α phosphorylation#induced translational repression, but that in fact 
as many mRNAs may be regulated at the level of translation as at the level of transcription 
(Smirnova et al., 2005). 
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Fig. 3. Global translational control by eIF2α phosphorylation. The three subunit#containing  
initiation factor eIF2 is part of the ternary complex in its GTP#bound form. During translation initiation, 
GTP is hydrolyzed. To regenerate active eIF2, bound GDP has to be exchanged for GTP; this reaction is 
catalyzed by the guanine nucleotide exchange factor (GEF) eIF2B. If eIF2 is phosphorylated on its alpha 
subunit, the dissociation rate of eIF2B is reduced so that the cellular pool of this exchange factor is 
depleted and eIF2 regeneration blocked. Pi – pyrophosphate (figure adapted from Gebauer & Hentze, 
2004). 
 
General translation rates are also regulated via the availability of the cap#binding protein eIF4E 
(reviewed in Rhoads, 2009). eIF4E interacts with the scaffold protein eIF4G and is required for 
cap#mediated recruitment of the 43S ribosomal complex to the mRNA (Gingras et al., 1999). The 
domain of eIF4G that is responsible for the association with eIF4E is shared by the 4E#binding 
proteins (4E#BPs), leading to a competition for eIF4E binding between eIF4G and 4E#BPs (refer 
to Fig. 4). Whereas interaction with eIF4G promotes translation initiation, association with a 4E#
BP inhibits the binding of the 43S complex to the mRNA. The activity of 4E#BPs is regulated by 
phosphorylation: Only the hypophosphorylated form binds to eIF4E, whereas hyper#
phosphorylation releases the interaction (Pause et al., 1994). The 4E#BPs of budding yeast, Eap1 
and Caf20, inhibit general translation initiation in response to stress conditions such as presence 
of cadmium and diamides in the growth medium or the occurrence of membrane stress (Deloche 
et al., 2004; Mascarenhas et al., 2008). In analogy to regulation exerted by phosphorylation of 
eIF2α, some mRNAs experience enhanced translation in a situation in which 4E#BPs are 
activated. For example, cap#independent translation is promoted (Svitkin et al., 2005) and has 
been demonstrated to be required for physiological adaptation to stress (Gilbert et al., 2007). 
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Fig. 4. Translational control by 4Ebinding proteins (4EBPs). 4E#BPs bind to the cap#binding 
protein eIF4E and thereby inhibit its interaction with eIF4G and the initiation machinery. This inhibitory 
association is released by phosphorylation of the 4E#BPs, upon which translation initiation can take place 
(figure adapted from Gebauer & Hentze, 2004). 
 
2.3.2. Targetspecific translational regulation 
Target#specific regulation affects only a limited number of transcripts and is in general driven by 
the association of regulatory protein complexes. Several features of an mRNA can act as binding 
motifs, including cap#structure and poly(A) tail, secondary and tertiary RNA structures  
(e.g. hairpins and pseudoknots), and specific sequence motifs that are recognized by regulatory 
proteins (Gebauer & Hentze, 2004). Most known regulatory sequences are found within the  
3' UTR, and it has been suggested that by adopting the closed#loop conformation (see figure 2; 
Wells et al., 1998), factors binding to the 3' UTR are brought in close proximity to the 5' end of 
the RNA, where they can modulate translation (Gebauer & Hentze, 2004).  
In the last section, the function of the 4E#BPs has been described. Whereas these regulators 
control translation of a large number of transcripts, mRNA#specific 4E#BPs have been 
characterized that equally bind eIF4E and prevent its interaction with eIF4G, but that are 
tethered to sequence#specific RBPs (Groppo & Richter, 2009). For instance, the 4E#BPs Maskin 
and Neuroguidin interact with the RBP CPEB (Stebbins#Boaz et al., 1999; Jung et al., 2006), Cup 
associates with Bruno (Nakamura et al., 2004), and CYFIP1 with the Fragile X mental retardation 
protein (FMRP) and a small noncoding RNA (Napoli et al., 2008).  
As a variation on this theme, a specific repressor of caudal mRNA, d4EHP (Drosophila eIF4E#
homologous protein), has recently been identified that directly interacts with the 5' cap, thus 
interfering with eIF4E binding. The specificity of this interaction is mediated by the simultaneous 
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interaction of d4EHP with Bicoid, which binds to a recognition motif within the 3' UTR of 
caudal mRNA (Cho et al., 2005). 
Cap# and poly(A) tail#independent translation inhibition is mediated by D. melanogaster Sex#lethal 
(Sxl). Sxl binds to recognition sites in both 5' and 3' UTRs of its target mRNA and recruits co#
repressors to the 3' UTR, which prevents the stable association of the 40S ribosomal subunit with 
the mRNA (Gebauer et al., 2003). An even later step in initiation is targeted by heterogeneous 
nuclear ribonucleoproteins K and E1 (hnRNP K/E1). During early erythroid differentiation, 
both proteins bind to a recognition motif in the 3' UTR of LOX mRNA. Although 48S#complex 
formation still occurs upon hnRNPK/E1 association, joining of the large ribosomal subunit is 
prevented, presumably by interference with the respective initiation factor(s) (Ostareck et al., 
1997; Ostareck et al., 2001).  
  
2.3.3. Control of translation elongation and termination 
Although initiation seems to be the most common target of translational control mechanisms, 
regulation of elongation and termination have also been reported (reviewed in Groppo & Richter, 
2009).  
In yeast, endoplasmic reticulum (ER) stress triggers the unfolded protein response (UPR) which 
results in an increase in the Hac1 transcription factor. Under non#stress conditions, unspliced 
HAC1 mRNA contains ribosomes that are stalled due to base#pairing between sequences in the 
intron and complementary sequences in the 5' UTR (Ruegsegger et al., 2001). The UPR induces 
recruitment of HAC1 to discrete foci of the ER where splicing via the stress sensor Ire1 occurs 
(Sidrauski & Walter, 1997), resulting in the alleviation of the stalled ribosomes and active 
translation (Ruegsegger et al., 2001). By modulating transcription, Hac1 induces the expression of 
genes that are essential to relieve ER stress, for example chaperones of the ER (Kaufman, 1999).  
Another example for a post#initiation regulatory control mechanism is the response of 
mammalian cells to nonSTOP mRNAs that lack in#frame stop codons. In contrast to yeast, 
mammalian cells do not show enhanced degradation of nuclear#encoded nonSTOP mRNAs 
(Akimitsu et al., 2007). Although nonSTOP mRNAs were found to be associated with 
polysomes, indicating unperturbed initiation, 14C#leucine incorporation experiments suggested 
premature ribosome termination (Akimitsu et al., 2007). The authors propose that this ribosome 
fall#off is due to stalling of ribosomes at the poly(A) tail of the mRNA which prevents upstream 
translation events. 
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A third mechanism that has been suggested to affect elongation is translational control exerted by 
miRNAs. Several authors report that repressed mRNAs are associated with polysomes, but are 
less actively translated (e.g. Nottrott et al., 2006; Petersen et al., 2006; Maroney et al., 2006). This 
repression seems to be independent of normal initiation, since IRES#mediated translation is 
equally affected (Petersen et al., 2006). Therefore, decreased elongation rates or ribosome drop#
off during elongation have been proposed to account for this type of miRNA#mediated control. 
However, the results are partly contradictory and the question as to which translation step is 
targeted by miRNAs – initiation or elongation – is currently a matter of active debate (reviewed 
in Jackson et al., 2010).  
The multiple functions that RBPs fulfill in the regulation of the mRNA lifecycle are reflected in 
their often modular domain structure which necessarily comprises RNA#binding domains 
(RBDs). While a large number of these domains have been characterized (for a review, see Lunde 
et al., 2007), the next chapter will focus on a specific class – the KH domain – that is of particular 
importance for this work. 
 
2.4. hnRNP Khomology (KH) domains interact with RNA 
Besides RNA#recognition motif (RRM) and double#stranded RNA#binding domain (dsRBD), the 
so#called KH domain belongs to the most frequent domains that interact with RNA. First 
identified in heterogeneous nuclear ribonucleoprotein K (hnRNP K) and accordingly named 
hnRNP K homology (KH) domain (Siomi et al., 1993), KH domains are ubiquitous in archaea, 
bacteria and eukaryota (Siomi et al., 1993; Grishin, 2001). In various studies, it has been shown 
that KH domains are responsible for the recognition of single#stranded nucleic acids (Valverde et 
al., 2008), and that the corresponding RNA# or ssDNA#binding proteins are involved in a 
plethora of biological functions, from splicing to transcriptional regulation and translational 
control (Valverde et al., 2008).  
A typical KH domain consists of approximately 70 amino acids that are structurally organized in 
a three#stranded antiparallel β#sheet packed against three α#helices (see Fig. 5). Based on their 
topology, KH domains can be grouped into two subfamilies: type I domains (typically present in 
eukaryotic proteins) have a β1α1α2β2β3α3 organization, whereas type II domains (typically found in 
prokaryotic proteins) have a α1β1β2α2α3β3 fold (Grishin, 2001). Between β2 and β3 (type I) or β1 
and β2 (type II) strands, KH domains possess a variable loop that can be formed by three up to 
more than 60 amino acids (Valverde et al., 2008) and is involved in nucleic acid binding (see 
below). Near the center (between helices α1 and α2), KH domains contain a conserved and 
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functionally important signature sequence comprising the typcial GXXG loop 
((I/L/V)IGXXGXX(I/L/V)). Only in few cases of diverged KH domains, the GXXG loop is 
altered, interrupted or missing (Brykailo et al., 2007a). In type I domains, the nucleic acid#binding 
cleft is composed of the structural elements helix α1, GXXG loop, helix α2, strand β2 and the 
variable loop between β2 and β3 (Fig. 5). Typically, this hydrophobic pocket accomodates four 
unpaired bases via Van der Waals forces, hydrophobic interactions and, to a lesser extent, 
electrostatic interactions (Valverde et al., 2008). Biochemical studies suggest that ssDNA and 
RNA are bound with a rather low micromolar affinity (Liu et al., 2001; Braddock et al., 2002). 
Therefore, one function of the frequently found array of multiple KH domains within the same 
protein may be to increase specificity and affinity by combination of multiple weak interactions 
(Lunde et al., 2007). For example, two KH domains are present in fragile X mental retardation 
protein (FMRP) (Ashley et al., 1993), three in hnRNP K (Siomi et al., 1993), and 14 in vigilin 
(section 2.5.; Dodson & Shapiro, 1997; McKnight et al., 1992). Cooperative function has for 
instance been demonstrated for the E. coli transcription elongation factor NusA whose two KH 
domains form an extensive area of interdomain contact and cooperatively bind an extended RNA 
segment (Beuth et al., 2005). However, multiple copies can also function independently, e.g. in 
FBP (Far#upstream element (FUSE)#binding protein), where KH domains 3 and 4 are separated 
by a flexible linker and individually bind to two different segments of ssDNA (Braddock et al., 
2002b). 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Common structural features of KH domainnucleic acid interactions. A typical binding cleft 
of KH domains comprises the secondary structural elements helix α1, GXXG loop, helix α2, strand β2, 
and variable loop (colored green). Four nucleotides (cyan sticks) can be accomodated within the binding 
pocket. Dotted green line: position of the variable loop in type II KH domains (figure from Valverde et 
al., 2008). 
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An extensively studied human KH domain#containing protein is FMRP, the lack of which leads 
to Fragile X mental retardation syndrome (D'Hulst & Kooy, 2009). Although in the majority of 
the cases, chromosomal fragility and transcriptional silencing of the FMRP#encoding gene is 
responsible for the disease (Jin & Warren, 2000), a single mutation within the conserved signature 
sequence of the second KH domain has been identified as cause for a severe peculiarity of the 
syndrome (De Boulle et al., 1993).  
In yeast, the KH domain with the highest sequence identity (50%) to the second KH domain of 
human FMRP has been found in Scp160 (Currie & Brown, 1999). However, Scp160 contains 14 
KH domains and is therefore unlikely to represent a yeast homologue of FMRP (Currie & 
Brown, 1999). Rather, Scp160 has been shown to belong to the highly conserved, multi KH 
domain#containing vigilin protein family which will be the focus of the next chapter. 
 
2.5. Vigilins – a conserved family of multi KHdomain proteins 
Vigilins, also known as high density lipoprotein#binding proteins, are a class of ubiquitous 
proteins that contain 14 related, but non#identical, KH domains. To date, vigilin homologues 
have been characterized in human (McKnight et al., 1992), chicken (Schmidt et al., 1992), 
Xenopus laevis (Dodson & Shapiro, 1997), Drosophila melanogaster (Cortes et al., 1999), 
Caenorhabditis elegans (Weber et al., 1997), Danio rerio (Chen et al., 2003), and Saccharomyces 
cerevisiae (Weber et al., 1997). Various biological functions have been assigned to the vigilin 
family members, including tRNA export (Kruse et al., 2000), formation of heterochromatin 
(Wang et al., 2005), and the selective protection of a specific transcript against endonuclease 
cleavage (Cunningham et al., 2000). In the following, the current knowledge about the so far 
best#characterized vigilins will be summarized. 
 
2.5.1. Human vigilin 
Human vigilin has first been described as a component of a cellular pathway that facilitates 
removal of excess cholesterol from cultured cells (McKnight et al., 1992). However, the presence 
of 14 consecutive KH domains (see Fig. 6) soon directed the attention to a potential function of 
vigilin in the cellular RNA metabolism. 
Vigilin contains a functional SV40#type nuclear localization sequence (NLS) between KH 
domains 2 and 3 and localizes to both nucleus and cytoplasm, as shown by immunofluorescence 
microscopy (Kugler et al., 1996). More precisely, vigilin was found to be present in the "ribosome 
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factory" of the cell, the nucleolus, where it may associate with ribosomal precursors (Kruse et al., 
2003). In affinity#purified nuclear multiprotein complexes, vigilin is present together with eEF1A, 
tRNA (Kruse et al., 1998) and the tRNA#specific nuclear export factor Exportin#t (Kruse et al., 
2000), suggesting that it may be involved in the coordination of the export of newly synthesized 
ribosomes and tRNAs (Kruse et al., 2003).  
In the cytosol, vigilin is as well complexed with eEF1A and tRNA (Kruse et al., 1998), but also 
associated with 80S ribosomes, and free# and membrane#bound polysomes (Vollbrandt et al., 
2004). By in vitro studies, it has been demonstrated that the C#terminal domain of vigilin directly 
interacts with a subset of ribosomal 40S and 60S proteins (Vollbrandt et al., 2004). Yet, the 
ribosome#associated function of vigilin is unclear. Whereas its expression levels were found to be 
co#regulated with translational activity of both secretory and intracellular proteins (Kruse et al., 
2003), indicating a general role in translation, siRNA#mediated knockdown had no effect on the 
overall rate of protein synthesis (Goolsby & Shapiro, 2003). However, depletion of vigilin 
presumably induces caspase#dependent apoptosis and is therefore lethal. It should be noted that 
the essential function of vigilin is independent of its potential role in chromosome partitioning 
during mitosis, since none#mitotic cells are equally susceptive to a vigilin knockdown (Goolsby & 
Shapiro, 2003). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. KH domain 14 of human vigilin. (A) Schematic representation of the eukaryotic type I KH 
domain fold. The KH minimal motif consisting of two alpha helices and two beta strands encompasses 
the highly conserved GXXG motif. The dotted line between strands β2 and β3 marks the position of the 
variable loop (figure adapted from Valverde et al., 2008). (B) Solution structure of the 14th KH type I 
domain from human vigilin. The structural motifs are numbered as in (A); GXXG# and variable loop are 
indicated (structure unpublished; DOI: 10.2210/pdb2ctm/pdb). 
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Besides its functions in tRNA export and presumably translation, vigilin has been implicated in 
the induction of heterochromatin. Wang and coworkers showed that both vigilin and DDP1, the 
D. melanogaster vigilin homologue (see section 2.5.3), have a high affinity for inosine#containing 
RNAs (I#RNAs) (Wang et al., 2005). I#RNAs are produced by the editing enzyme adenosine 
deaminase (ADAR) which converts adenosine residues to inosine. In the nucleus, double#
stranded RNAs are involved in heterochromatin formation via the RNAi pathway (Moazed et al., 
2006), but can also be targeted and edited by ADAR (Gerber & Keller, 2001). Using affinity 
chromatography, vigilin was found to bind nuclear I#RNAs in a complex with ADAR, DNA#
dependent protein kinase, RNA helicase A, the Ku70/Ku86 complex, histone variant H2AX and 
heterochromatin protein HP1α (Wang et al., 2005). As part of this complex, vigilin recruits the 
histone methyltransferase SUV39H1 that methylates histone H3 on lysine 9, supports binding of 
HP1, and thus strongly promotes heterochromatin formation (Zhou et al., 2008). Taken together, 
the authors propose a model in which, first, bidirectional transcription of repetitive elements – 
for example retrotransposons, centromeric or telomeric sequences – produces dsRNA. Second, 
this dsRNA is edited by ADAR and subsequently recognized by vigilin, which in turn recruits the 
machinery that induces heterochromatin formation and thus silencing of nearby DNA sequences 
(Zhou et al., 2008).  
 
2.5.2. Vigilin in Xenopus laevis 
In contrast to human vigilin which has been implicated in serveral different processes, only one 
defined function has so far been assigned to the homologue in the African clawed frog: the 
stabilization of specific mRNAs. 
mRNA turnover in the liver of X. laevis is regulated by the steroid hormone estrogen, which 
among others stabilizes the mRNA encoding vitellogenin (Brock & Shapiro, 1983) and 
destabilizes albumin mRNA (Pastori et al., 1991). Estrogen induces the expression of vigilin, 
which binds to a region of the vitellogenin mRNA 3' UTR (Dodson & Shapiro, 1994) that has 
been implicated in the control of vitellogenin mRNA stability (Nielsen & Shapiro, 1990). This 
region contains two copies of a consensus sequence that is recognized by PMR#1 endonuclease. 
Upon estrogen induction, these sequences are masked by vigilin, which protects vitellogenin 
mRNA from degradation. Albumin mRNA, in contrast, also contains the PMR#1 recognition 
motif, but is not bound by vigilin and is therefore degraded (Cunningham et al., 2000). By in vitro 
genetic selection, it was demonstrated that X. laevis vigilin preferentially associates with largely 
unstructured, single#stranded RNA stretches containing multiple (A)nCU and UC(A)n motifs. 
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Deletion analysis indicated that approximately 75 nucleotides are required for maximal binding 
(Kanamori et al., 1998), suggesting that more than one KH domain is involved. 
 
2.5.3. DDP1 is the vigilin homologue in Drosophila melanogaster 
As mentionend in section 2.5.1, not only human vigilin, but also the D. melanogaster vigilin 
protein DDP1 binds to I#RNAs with high affinity (Wang et al., 2005). This finding suggests that 
DDP1 may act in heterochromatin formation in the same way as has been described for vigilin, 
which indeed seems to be the case. It has been shown that DDP1 colocalizes with 
heterochromatin protein HP1 to heterochromatic regions in polytene chromosomes and in nuclei 
from larval neuroblasts (Cortes et al., 1999). HP1 is known to play a central role in organizing 
heterochromatin (Eissenberg & Elgin, 2000), and if DDP1 is mutated, HP1 deposition at the 
chromocenter of polytene chromosomes is strongly reduced, along with H3#K9 methylation 
which is a prerequisite for HP1 association (Huertas et al., 2004; Hall et al., 2002). Furthermore, 
DDP1 is associated with condensed mitotic chromosomes and is required for correct 
chromosome condensation and segregation (Cortes et al., 1999). These data suggest that DDP1 is 
involved in heterochromatin formation, and indeed, a mutant allele of DDP1 behaves as a 
dominant suppressor of heterochromatin#induced position effect variegation (Huertas et al., 
2004). This phenomenon is based on the inactivation of a gene through its juxtaposition with 
heterochromatin, and its suppression by a DDP1 mutation indicates that this protein contributes 
to the formation of heterochromatin and gene silencing.  
Apart from its heterochromatin#related function, DDP1 has been demonstrated to function in 
translational control of a specific transcript (Nelson et al., 2007). D. melanogaster Hsp83 mRNA 
contains a sequence element in its 3' UTR, the so#called Hsp83 degradation element (HDE), that 
functions in stimulating translation (Bashirullah et al., 1999). Using tandem RNA affinity 
purification (TRAP), Nelson and colleagues identified DDP1 to bind to the HDE along with 
Hrp48 and Poly(A) binding protein. In this regulatory complex, both DDP1 and Hrp48 function 
in translational enhancement (Nelson et al., 2007). 
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2.5.4. Scp160, the yeast homologue of vigilin 
In the budding yeast, Scp160 has been characterized as member of the vigilin protein family 
(Weber et al., 1997). Although its primary sequence shows only about 20% identity with the 
vigilins of human, chicken and C. elegans (Weber et al., 1997), its array of 14 KH domains closely 
corresponds to the structure of vertebrate vigilins. However, whereas 12 KH domains of human 
vigilin contain a perfect GXXG motif, only seven of Scp160's KH domains contain a strictly 
conserved KH motif (domains 2, 8#12 and 14), while the remaining seven are diverged and 
display alterations in the GXXG motif or contain no GXXG motif at all (Figure 7; Weber et al., 
1997).  
 
 
 
 
 
Fig. 7. Domain structure of Scp160. The schematic representation illustrates that Scp160 is essentially 
made up of 14 KH domains, seven of which contain conserved GXXG loops (marked in blue) whereas 
the remaining seven carry altered or no GXXG motifs (marked in yellow). The positions of the putative 
nuclear export (NES) and nuclear localization (NLS) sequences are indicated (see section 2.6.3.). 
 
In the next chapter, the current status of knowledge regarding the cellular functions of Scp160 – 
and therefore the starting point of the present study – will be reviewed.  
 
2.6. Scp160 is implicated in diverse cellular processes 
2.6.1. Ploidy control  
Yeast strains in which Scp160 is deleted show an abnormal morphology with larger cell size and 
increased DNA content, along with irregular segregation of genetic markers. These observations 
indicate that Scp160 is a factor that is involved in the maintenance of cellular ploidy, and the 
protein has been named accordingly (S. cerevisiae protein controlling the ploidy) (Wintersberger 
et al., 1995). Interestingly, once established, this phenotype cannot be rescued by a plasmid#borne 
copy of Scp160. Since immunofluorescence microscopy illustrated that in addition to a 
cytoplasmic pool, Scp160 localizes to the nuclear envelope and to the ER, the authors 
hypothesized that Scp160 may be required for proper partitioning of this membraneous network 
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during cell division (Wintersberger et al., 1995). Because yeast cells undergo closed mitosis, i.e. 
chromosome segregation takes place within the intact nucleus, unfaithful partitioning potentially 
induces ploidy aberrations. However, upon the finding that Scp160 contains nucleic acid#binding 
domains and associates with translating ribosomes, it has been suggested that the 
ploidy phenotype of the deletion strains may be induced indirectly by defects in the metabolism 
or translational control of target transcripts (see sections 2.6.2. and 2.6.5; Weber et al., 1997). 
 
2.6.2. Scp160 associates with RNA 
Using Northwestern blotting, Weber and coworkers (1997) demonstrated that purified Scp160 
binds to all four ribohomopolymers, but exhibits the highest affinity for poly(rG). In subsequent 
competition experiments, rRNA was the most efficient competitor of poly(rC) binding, whereas 
double#stranded and single#stranded DNA competed less efficiently. tRNA did not compete with 
poly(rC) binding, indicating that in contrast to human vigilin (see section 2.5.1.), Scp160 may not 
be involved in tRNA#related processes. The assumption that Scp160 binds cellular mRNAs was 
supported by the finding that Scp160 is associated with polysomes as part of a RNase#sensitive 
protein complex (Lang & Fridovich#Keil, 2000). The final confirmation that Scp160 associates 
with mRNAs came from two studies in which Scp160#bound material was used for microarray 
analysis, revealing that Scp160 binds a rather large set of transcripts (Li et al., 2003; Hogan et al., 
2008). 
 
2.6.3. Regulation of telomeric silencing 
As described in sections 2.5.1. and 2.5.3., vigilins are involved in the structural organization of 
heterochromatin both in human and D. melanogaster. Although the factors that mediate 
transcriptional silencing and heterochromatin formation in budding yeast are different from those 
in fission yeast and higher eukaryotes, Scp160 has also been found to play a role in silencing. 
Marsellach and coworkers (2006) showed that deletion of Scp160 relieves silencing at telomeres 
and at the mating#type locus, which goes along with decreased deposition of the silencing protein 
Sir3. Whereas Sir3 is required for heterochromatin formation and silencing at telomeres and the 
mating#type locus, it is not involved in the same processes at the rDNA locus; notably, silencing 
of the rDNA locus is not affected by deletion of Scp160. Interestingly, the contribution of 
Scp160 to silencing is independent of either its effect on cell ploidy or its binding to ribosomes 
(Marsellach et al., 2006). Although Scp160 contains a nuclear localization# as well as a nuclear 
export signal, there is so far no experimental evidence that full#length Scp160 enters the nucleus 
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(Brykailo et al., 2007b). Consistently, Scp160 was not found to associate with telomeric DNA in 
ChIP experiments (Marsellach et al., 2006). The authors rather suggest that the silencing function 
is connected to the localization of Scp160 to the nuclear envelope, since telomere clustering at 
the nuclear envelope – which facilitates telomeric silencing – is perturbed in scp160@ cells.  
 
2.6.4. A functional role in the mating response pathway 
In the yeast mating response pathway, receptor stimulation by pheromones leads to the activation 
of a heterotrimeric G protein composed of an α subunit (Gpa1) and a tightly associated βγ dimer. 
Upon activation, the βγ dimer is released and activates downstream signaling proteins. Guo and 
colleagues (2003) demonstrated for the first time that also Gpa1 has a positive signaling function. 
Unexpectedly, in a genome#wide two#hybrid screen, Scp160 was identified as a putative binding 
partner of Gpa1 (Uetz et al., 2000). Further experiments showed that Scp160 associates 
preferentially with the activated form of Gpa1 and that it is essential for the transmittance of the 
pheromone signal by Gpa1 (Guo et al., 2003). These results raise the intriguing possibility that 
the RNAs that are targeted by Scp160 may act as a form of "second messenger" in signaling 
networks.  
 
2.6.5. Translational control 
Numerous findings indicate that Scp160 may be involved in translational control:  
First, scp160 deletion strains show increased sensitivity against translation inhibitors such as 
cycloheximide and hygromycin B (Baum et al., 2004).  
Second, Scp160 is known to associate with cytosolic and membrane#bound polysomes (Frey et 
al., 2001), from which it is released by EDTA treatment as component of mRNP complexes. 
These large complexes contain the poly(A) binding protein Pab1 (Lang & Fridovich#Keil, 2000) 
and the RBP Bfr1. Bfr1, which has originally been implicated in the secretory pathway (Jackson 
& Kepes, 1994), colocalizes with Scp160 to ER and nuclear envelope and equally associates with 
polysomes. Interestingly, there is evidence that Bfr1 is required for polysome (but not ribosome) 
association of Scp160 (Lang et al., 2001). The binding site of Scp160 on the ribosome was 
localized to the ribosomal 40S subunit close to the mRNA exit tunnel (Baum et al., 2004), which 
is consistent with the idea that Scp160 actively contributes to the association of mRNAs with 
especially ER#bound ribosomes and/or controls translation of (specific?) transcripts (Frey et al., 
2001). Scp160's association with the ribosome is partially dependent on its interaction with Asc1, 
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the yeast orthologue of mammalian receptor of activated C#kinase (RACK1) (Gerbasi et al., 2004; 
Baum et al., 2004). RACK1 integrates inputs from different signaling pathways on the ribosome 
and regulates translation by recruiting activity#modulating protein kinases (Nilsson et al., 2004).  
Third, deletion of Scp160 is synthetic lethal with the eIF4E#binding protein Eap1 (Mendelsohn et 
al., 2003). Scp160 acts in concert with Eap1 in the so#called SESA network in order to inhibit 
translation of POM34 mRNA in response to spindle pole body duplication defects (Sezen et al., 
2009). However, this finding does not explain why Scp160 and Eap1 are synthetic lethal in 
otherwise wildtype cells, suggesting that the SESA network is only one part of a translational 
control system involving both proteins.  
Finally, there is evidence that Scp160 is involved in the elongation step of translation, since it can 
form chemical crosslinks with elongation factor 1A (eEF1A) on the ribosome (Baum et al., 2004). 
In addition, the mammalian Scp160 homologue vigilin co#purifies in a complex with eEF1A and 
tRNA (refer to section 2.5.1.; Kruse et al., 1998; Kruse et al., 1996).  
Taken together, these findings strongly suggest that Scp160 functions in the regulation of 
translation.
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3. Aims of  this study 
At the starting point of this study, several lines of evidence implicated Scp160 in translational 
control: The increased sensitivity of Scp160#deprived cells against translation inhibitors, Scp160's 
association with membrane#bound and cytosolic polysomes, its binding site on the ribosome 
close to the signal adapter Asc1 (RACK1) and elongation factor eEF1A, as well as its synthetic 
lethality with the eIF4E#binding protein Eap1. However, genome#wide studies addressing the 
suggested function of Scp160 in translation were missing. 
The present study focused on two major points: First, the interaction of Scp160 with ribosomes 
should be closer examined, and second, a translational profiling approach should be performed 
to identify mRNAs that are post#transcriptionally regulated by Scp160. To address the first 
question, affinity purifications of Scp160 should be used to identify so far unknown interaction 
partners as well as to recheck the suggested dependence of its ribosome interaction on RNA, 
Asc1 and the C#terminal KH domains. Further, fractionation experiments should be used to test 
if ribosome association is lost under specific conditions. In the second part of this work, changes 
in the transcriptome as well as changes in translation rates upon depletion of Scp160 should be 
determined by microarray analysis. Candidate mRNAs should be verified as direct targets of 
Scp160 by immunoprecipitation experiments, and their putative function with respect to the 
polyploidy phenotype of Scp160#deficient cells should be illuminated. 
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4. Results 
4.1. Scp160 interacts with ribosomes 
It has been demonstrated that the RNA#binding protein Scp160 associates with cytosolic and 
membrane#bound polysomes (Frey et al., 2001; Lang & Fridovich#Keil, 2000; Mendelsohn et al., 
2003; Weber et al., 1997). These results are based on sucrose density fractionation studies, in 
which Scp160 has been shown to be present in the polysome#containing gradient fractions. To 
gain an independent picture of Scp160's ribosome association as well as to possibly identify to 
date unknown interaction partners, I isolated Scp160#containing complexes by Tandem Affinity 
Purification (TAP) (Rigaut et al., 1999). 
 
4.1.1. Scp160 copurifies with ribosomal proteins in a partially RNA
dependent manner 
Carboxyterminally TAP#tagged Scp160 was regarded as being functional, since the tagged strain 
did not display reduced fitness, as is the case for scp160 deletion strains (not shown). The TAP 
procedure contains two subsequent purification steps, namely binding to IgG affinity resin 
through the protein A part of the tag and association with calmodulin beads through the 
calmodulin binding peptide moiety. The two parts of the tag are separated by a TEV protease 
cleavage site that is used to specifically cleave off bound complexes from the IgG beads (Rigaut 
et al., 1999). In my purifications of Scp160, I found that application of the whole purification 
procedure disrupted the association of Scp160 with its interactors (see Fig. 9, "CaM"), whereas 
applying only the IgG binding step together with a higher volume of wash buffer (see section 
6.2.12.2.) resulted in specific co#purification of a number of proteins (Fig. 8, lane 3).  
As shown in Fig. 8, TEV eluates of Scp160 purifications contain several co#purifying proteins, 
most of wich can be assigned to components of the 80S ribosome as indicated by comparison 
with an 80S purification (lane 1). The interaction with these proteins is specific, since they are not 
present in a mock purification of an untagged wildtype strain (lane 2). Mass spectrometric 
analysis confirmed the presence of components of both small (Rps3, Rps0A, Rps0B, Rps5, 
Rps16A, Rps16B) and large (Rpl3, Rpl4A, Rpl5) ribosomal subunits. These results are in 
accordance with a large#scale survey, in which a set of ribosomal proteins has been found to co#
purify with TAP#tagged Scp160 (Gavin et al., 2006). I further confirmed the association with the 
yeast homologue of mammalian RACK1, Asc1, which is involved in polysome binding of Scp160  
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Fig. 8. Scp160 interacts with ribosomal proteins in a partially RNAdependent manner. TAP#
tagged Scp160 (strain RJY2946) was purified up to the TEV cleavage step and incubated for 10 min with 
or without 5 Vg RNase A. Co#purifying proteins were separated by SDS#PAGE and visualized by 
Coomassie staining. Bands of interest were excised and analyzed by mass spectrometry. For comparison, 
purified 80S ribosomes (courtesy of T. Becker) were loaded. Untagged wildtype extract (RJY358) served as 
mock control. Ribosomal proteins are marked with a star (*), ribosome#associated proteins are indicated 
with a cross (+). 
 
(Baum et al., 2004), and Bfr1, which previously has been shown to associate with Scp160#
containing complexes and polysomes (Lang et al., 2001). In addition, I identified two further 
proteins to be present in Scp160 purifications, namely Stm1 and Zuo1, which previously have 
been shown to associate with ribosomes (Van Dyke et al., 2006; Gautschi et al., 2001).  
To test if the interaction of Scp160 with its co#purifiers is RNA#dependent, I treated IgG#bound 
material with RNase A prior to washing and TEV cleavage. Although all interactions were 
diminished, they were reduced at different degrees (Fig. 8, lane 4). Whereas association with Bfr1 
was lost completely, ribosomal proteins including Stm1 were still found in the eluate.  
 
4.1.2. Scp160, Bfr1 and Stm1 bind to overlapping sets of ribosomes 
Having confirmed the interaction between Scp160 and Bfr1 and identified Stm1 as co#purifier of 
Scp160, I asked whether Scp160 can also be found in the reverse purifications (Bfr1 and Stm1 as 
baits, respectively). As expected, Scp160 was present in Bfr1#TAP TEV eluates as a prominent 
band (Fig. 9, left panel). Together with the fact that Scp160# and Bfr1 purifications show a very 
RESULTS 
 - 24 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Scp160, Bfr1 and Stm1 associate with overlapping sets of ribosomes. TAP#tagged proteins 
(from strains RJY2946, RJY3391 and RJY3179) were purified either up to TEV elution (TEV), or 
including binding to calmodulin beads (CaM). Co#purifying proteins were separated by SDS#PAGE and 
visualized by Coomassie staining. Co#purifiers are marked with a star (*), TAP#tagged proteins are labeled 
with a cross (+). 10% (left panel) and 12% (right panel) polyacrylamide gels were used.  
 
similar pattern of co#purifying proteins, this suggests that both proteins localize to the same 
complexes. In contrast, in Stm1#TAP purifications, Scp160 was not visible as co#purifier on 
Coomassie level (Fig. 9, right panel). This could mean that although Stm1 is present in 
considerable amounts on ribosomes that are associated with Scp160, Scp160 in reverse is present 
on only a very small subset of ribosomes that contain Stm1. 
 
4.1.3. Ribosome association of Scp160 is only partially dependent on KH 
domains 13/14 and Asc1 
Several studies have shown that deletion of KH domain 14 reduces co#fractionation of Scp160 
with polysomes (Li et al., 2004), whereas deletion of KH domains 13 and 14 disrupts this 
association (Brykailo et al., 2007a; Baum et al., 2004). Similarly, deletion of Asc1 has been shown 
to diminish polysome association of Scp160 (Baum et al., 2004). Since these results are based on 
co#fractionation in sucrose density gradients, I decided to use the TAP system in order to check 
ribosome binding in a more direct way. 
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Fig. 10. Ribosome association of Scp160 is only partially dependent on KH domains 13/14 and 
Asc1. TAP purifications of full#length Scp160#TAP and Scp160KH13/14#TAP in both wildtype (strains 
RJY2946 and RJY3256) and asc1 (RJY3231 and RJY3258) background, were performed up to TEV 
cleavage. Co#purifying proteins were separated by SDS#PAGE and visualized by Coomassie staining. 
Ribosomal proteins are labeled with a star (*), ribosome#associated proteins are marked with a cross (+).  
 
Interestingly, both deletion of KH domains 13/14 and deletion of Asc1 induced only a slight 
reduction in the co#purification of ribosomal proteins (Fig. 10). Even in a strain carrying both 
KH domain 13/14 truncation and asc1 deletion, significant amounts of ribosomal proteins are 
present in the TEV eluate (Fig. 10, lane 5). These results suggest that even if polysome 
association may be reduced under these conditions, Scp160 largely retains its ability to bind to 
ribosomes. 
 
4.2. Scp160 associates with ribosomecontaining cellular subfractions 
4.2.1. Deletion of KH domains 13/14 induces a nonribosome associated 
pool of Scp160 
In subcellular fractionation experiments, Scp160 has been demonstrated to co#fractionate with 
ER membranes, but also with the cytosolic ribosome fraction. Ribosome#depleted cytosol, in 
contrast, is free of Scp160 (Frey et al., 2001). In my TAP experiments, I found that ribosome 
association of Scp160 truncations as well as of Scp160 in an asc1 deletion background is slightly 
reduced (see Fig. 10). To test if this reduction induces changes in the subcellular localization of 
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Scp160, I carried out fractionation experiments as described by Frey and coworkers (Frey et al., 
2001).  
Briefly, three subsequent centrifugation steps applied to whole cell extracts result in three pellet 
fractions enriched in ER membranes and ribosomes (P6 – ER fraction, P18 – ER and heavy 
polysomes, P200 – cytosolic ribosomes) and a ribosome#free, cytosolic supernatant (S200) (Fig. 
11A). Successful separation of these fractions was confirmed by immunoblotting against the ER#
protein Sec61 (only present in P6), ribosomal protein Rps3 (in all pellet fractions, but not in the 
cytosolic fraction S200), and cytoplasmic phosphoglycerate kinase (Pgk1; only present in S200) 
(Fig. 11B). Probing with an anti Scp160 antibody showed that Scp160 colocalizes with ribosome#
containing fractions (lanes 1#4; enrichment in the ER fraction P6, presence in ribosomal fractions 
P18 and P200). As expected, no signal was present in the cytosolic supernatant S200.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Scp160's association with ribosomecontaining cellular subfractions is independent of 
Asc1 and partially dependent on KH domains 13 and 14. (A) Schematic of the subcellular 
fractionation assay. Whole cell extracts derived from glass bead lysis were subjected to three subsequent 
centrifugation steps as indicated. (B) Fractionation assay of wildtype (RJY3515), asc1 (RJY3000) and 
scp160(KH13/14 (RJY3516) strains. Aliquots of the different centrifugation steps were separated by SDS#
PAGE and probed for Scp160, the ER marker protein Sec61, the cytosolic marker protein Pgk1, and 
ribosomal proteins Asc1 and Rps3. 
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Interestingly, deletion of asc1 did not change this fractionation pattern (lanes 5#8), whereas 
truncation of Scp160 by KH domains 13 and 14 induced the additional appearance of a non#
ribosomal, cytosolic pool (lanes 9#12). This may reflect that KH domains 13 and/or 14 are 
involved in ribosome association or in Scp160's interaction with other high molecular complexes. 
 
4.2.2. Mutation of conserved RNA binding domains causes partial loss of 
ribosome association 
As described in paragraph 4.2.1., deletion of the two last KH domains causes an additional 
cytoplasmic pool of Scp160. To analyze if this effect is due to loss of the specific RNA#binding 
activity of these domains, I generated versions of Scp160 that contain point mutations within the 
conserved RNA#binding pockets of KH domains 13 and 14. Analogous mutations in other KH#
domain containing proteins have been previously shown to interfere with RNA binding (Siomi et 
al., 1994; Jones & Schedl, 1995; Chmiel et al., 2006). As target sequence I chose the GXXG 
region that is the most conserved stretch in all KH domains described to date (refer to section 
2.4 and Fig. 12). I introduced the following amino acid exchanges: glycine 1028 to aspartate, 
isoleucine 1031 to asparigine, glycine 1170 to aspartate, and glycine 1173 to aspartate (Fig. 12A). 
The resulting proteins, Scp160mutKH14 (with mutations G1170D and  G1173D) and 
Scp160mutKH13/14 (with additional mutations G1028D and I1031N) were expressed as myc9#
tagged versions from a low copy vector. Although their expression was higher than that of 
endogenous Scp160, they were detectable at similar levels as a wildtype myc9#tagged Scp160 
expressed from the same vector (Fig. 12B).  
In subcellular fractionation, plasmid#derived Scp160 distributed over the different fractions 
essentially as described before (Fig. 12C, compare to Fig. 11B). However, even in case of the 
wildtype construct (lanes 1#4), a small portion of Scp160 was present in the cytoplasmic fraction 
S200. This is probably due to the aforementioned overexpression of the constructs (Fig. 12B). In 
the point mutants (lanes 6#12), the cytoplasmic pool of Scp160 was increased, although the 
strongest signal was still detected in the ER fraction P6. These findings indicate that RNA#
binding activity mediated by KH domains 13 and 14 contributes to the association of Scp160 
with ribosomes or other large mRNP complexes. In this context, it is important to mention that 
in the further course of this study, I could confirm that the point mutants described here are 
deficient in the binding of target mRNAs (see section 4.6.2).  
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Fig. 12. Point mutations in the RNA binding pockets of KH domains 13 and 14 induce a non
ribosome associated pool of Scp160. (A) Sequence alignment of the GXXG regions of KH domains 13 
and 14 of S. cerevisiae Scp160 and its orthologues in G. gallus, H. sapiens, X. laevis and D. melanogaster. 
GXXG motifs and the higly conserved isoleucins are boxed, residues that were mutated in this study are 
underlined. (B) Western blot of whole cell extracts using antibodies against Scp160 and actin (loading 
control). Compared to the expression of the endogenous gene (in strain RJY358), Scp160 amounts are 
elevated if expressed from the centromeric plasmid pRS316 (strains HSY9, HSY11, HSY10 and HSY12). 
(C) Analysis of subcellular fractionation samples. Lysates were prepared from cells expressing wildtype 
Scp160 (HSY11), Scp160 with point mutations in KH domain 14 (G1170D and G1173D; HSY10) or in 
KH domains 13 and 14 (additionally G1028D and I1031N; HSY12). Subcellular localization of Scp160, 
Pgk1, Sec61 and Rps3 was examined by immunoblotting. 
 
 
4.2.3. Scp160's subcellular localization remains unchanged upon diverse 
environmental changes 
Scp160 has been suggested to function in translational control of specific mRNAs (Weber et al., 
1997; Li et al., 2003; Frey et al., 2001), an assumption that has been confirmed recently for 
POM34 mRNA in response to spindle pole body defects (Sezen et al., 2009). Considering the 
subcellular localization of Scp160, one can assume that target mRNAs may preferentially be 
translated at the ER. Furthermore, Scp160 interacts with the signal integrator Asc1 on the 
ribosome (Baum et al., 2004; Nilsson et al., 2004) and has been shown to act as an effector in the 
RESULTS 
 - 29 - 
mating response pathway (Guo et al., 2003). Taken together, this raises the question if Scp160 
may integrate incoming signals to then adapt translation of its target mRNAs. I reasoned that this 
putative adaptation may involve differential association of Scp160 with ER membranes, and I 
therefore investigated if different environmental (stress) conditions influence the subcellular 
localization of Scp160. 
 
4.2.3.1. Pheromone treatment 
Since Scp160 acts as a component of the mating response pathway (Guo et al., 2003), I first 
tested if treatment of MATa cells with alpha factor induces a shift in the subcellular localization 
of Scp160. FACS analysis of wildtype cells that were incubated with 20 ng/ml alpha factor 
showed that this concentration was sufficient to induce the expected block in cell cycle 
progression (Fields, 1990), which results in the accumulation of cells with a 1n DNA content 
(Fig. 13A, left panel). Control treatment did not lead to changes in the corresponding FACS 
profiles (Fig. 13A, right panel). Samples of alpha factor#treated cells were taken during a time 
course of 90 min and subjected to subcellular fractionation. Immunoblotting showed that the 
association of Scp160 with the different fractions was unchanged (Fig. 13B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. Pheromone treatment does not induce a shift in the subcellular localization of Scp160. (A) 
Wildtype MATa cells (RJY358) were treated with 20 ng/ml alpha factor or with solvent alone (control). At 
the time points indicated, aliquots were removed, fixed and analyzed by flow cytometry. (B) Wildtype 
MATa cells (RJY358) were treated with alpha factor as in (A). At the indicated times, aliquots were 
collected and cells were snap#frozen in liquid nitrogen. Subcellular fractionation and immunoblotting were 
conducted as described above (see Fig. 11). Representative blots of three independent experiments are 
shown. 
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4.2.3.2. Heat shock 
As mentionend above, mRNAs translated at the ER are likely targets of Scp160. One subgroup 
of ER#localized transcripts encodes cell wall proteins that are directed to the extracellular surface 
of the plasma membrane through the secretory pathway (Lesage & Bussey, 2006). Assuming that 
Scp160 may control translation of those mRNAs, its ribosome association may be influenced by 
cell wall stress. Besides others, growth at elevated temperatures is a well#known condition that 
induces this kind of stress (Levin, 2005).  
To test if higher temperatures induce changes in the subcellular localization of Scp160, I shifted 
wildtype cells from 30°C to 40°C and collected samples for fractionation assay and RNA 
preparation at two different timepoints (Fig. 14). Already after 10 min, the heat#shock protein# 
encoding HSP42 mRNA (Wotton et al., 1996) was 50#fold induced as determined by qRT#PCR, 
indicating that the cells were responding to the heat stress as expected (Fig. 14, left panel). 
However, Western analysis of subcellular fractions showed that Scp160 retained its characteristic 
fractionation pattern also upon heat stress (Fig. 14, right panel). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Heat shock does not cause a shift in the subcellular localization of Scp160. Logarithmically 
growing wildtype cells (RJY358) were collected by centrifugation and resuspended in medium pre#warmed 
to 30°C or 40°C. Aliquots for subcellular fractionation and preparation of RNA were removed after the 
indicated times. Left panel: qRT#PCR analysis of the heat#shock inducible HSP42 mRNA was used as 
control (duplicate analysis). Right panel: Fractionation samples were assayed by immunoblotting. 
Representative blots of two independent experiments are shown. 
 
 
RESULTS 
 - 31 - 
4.2.3.3. Hyperosmotic shock 
Besides elevated temperatures, hyperosmotic shock is a stress condition that induces a cell wall 
integrity pathway#triggered response (Levin, 2005). Therefore # and for the reasons stated in 
section 4.2.3.2. #, hyperosmotic shock could induce changes in the localization pattern of Scp160.  
To address this question, I subjected wildtype cells to high salt concentrations (0.4 M NaCl) and 
took aliquots for subcellular fractionation as well as qRT#PCR. The latter showed that the level of 
the hyperosmolarity#responsive HOR2 mRNA (Hirayama et al., 1995) is more than 150#fold 
increased 15 min after onset of the salt stress (Fig. 15, left panel), which denotes that the 
osmosensing signal transduction pathway has been activated (Norbeck et al., 1996). However, 
also this cell wall stress#inducing condition did not exert any influence on Scp160's subcellular 
fractionation pattern (Fig. 15, right panel). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Mild hyperosmotic shock does not lead to a redistribution of Scp160 within subcellular 
fractions. Logarithmically growing wildtype cultures (RJY358) were supplemented with 0.4 M NaCl. 
Samples for subcellular fractionation and RNA preparation were taken at the indicated time points. Left 
panel: As a control, relative HOR2 mRNA levels were determined by qRT#PCR analysis (sample 
duplicates). HOR2 is known to be induced by hyperosmotic conditions. Right panel: Representative 
Western blots of the fractionation samples.  
 
4.2.3.4. Tunicamycininduced ER stress 
Accumulation of unfolded proteins in the ER causes stress and induces the unfolded protein 
response (UPR), which in turn upregulates expression of specific target genes that are involved in 
the release of the folding stress (Travers et al., 2000). Assuming that Scp160 is involved in the 
translational control of transcripts translated at the ER, I hypothesized that Scp160 may be 
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targeted by the UPR in order to diminish translation of its target mRNAs and therefore the load 
of unfolded polypeptides in the ER. ER stress can for example be induced by treatment with 
tunicamycin, a drug that inhibits N#linked glycosylation (Mahoney & Duksin, 1979).  
To test this hypothesis, logarithmically growing cultures were supplemented with 1 Vg/ml 
tunicamycin. qRT#PCR analysis confirmed that this concentration of the drug was sufficient to 
trigger UPR, as mRNA levels of the known UPR target LHS1 (Chapman et al., 1998) were more 
than three#fold induced upon treatment (Fig. 16, left panel). Samples were also subjected to 
subcellular fractionation and analyzed by immunoblotting (Fig. 16, right panel). Also upon 
induction of ER stress, Scp160 showed its normal distribution pattern.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16. Tunicamycininduced ER stress does not lead to a shifted subcellular localization of 
Scp160. Logarithmically growing wildtype cells (RJY358) were incubated with 1 Vg/ml tunicamycin. 
Samples were taken at the indicated times and used for subcellular fractionation and preparation of RNA. 
Left panel: Upregulation of LHS1 mRNA levels, as shown by qRT#PCR, served as control for the 
induction of the unfolded protein response (duplicate analysis). Right panel: Western analysis of the 
fractionation samples; representative blots of two independent experiments are shown. 
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4.3. A possible role for Scp160 in translation 
4.3.1. scp160 deletion strains display reduced fitness and sensitivity against 
translation inhibitors 
Yeast strains with defects in the translation machinery generally display reduced fitness such as 
slow or thermosensitive growth (Cuesta et al., 1998). As an indirect test for a putative function of 
Scp160 in translation, I compared growth of scp160@ and wildtype cells spotted in 10#fold serial 
dilutions on complete medium and incubated for three days at 20°C, 30°C and 37°C. At all 
temperatures tested, scp160 deleted cells demonstrated slightly impaired growth (Fig. 17, left 
panel). As a more specific assay, the effect of two drugs that inhibit translation, hygromycin B 
and cycloheximide (CHX), on scp160 strains was tested. Serial dilutions of wildtype and 
scp160@ cell suspensions were spotted on complete medium complemented with the respective 
drug, and growth was compared after three days incubation at 30°C. The deletion mutant showed 
a decrease in cell viability in this assay (Fig. 17, right panel), although growth was not as strongly 
impaired as has been reported before (Baum et al., 2004). My data suggest that Scp160 may be to 
some degree involved in general translation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17. scp160 cells display reduced fitness and increased sensitivity against translation 
inhibitors. Ten#fold serial dilutions of wildtype (RJY358) and scp160 (RJY3178) cell suspensions were 
spotted on YEPD plates and incubated for three days at the indicated temperatures (left panel). To test 
for defects in translation, cells were spotted on YEPD plates supplemented with 75 VM hygromycin B 
(HygB) or 0.2 VM CHX and incubated for three days at 30°C (right panel).  
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4.3.2. Translation initiation is slightly impaired in scp160 deletion strains 
Polysome profiling has been described as an ultimate phenotypic proof for translation defects 
(Lee et al., 2007). In order to assess if Scp160 causes changes in the proportion of actively 
translating ribosomes, polysome profile analyses were carried out for wildtype and scp160 
strains. Whole cell extracts were centrifuged through linear sucrose gradients and absorbance 
profiles were continuously measured. From these graphs, areas corresponding to translating 
polysomes (P) and translationally less active monosomes (M) were determined. The P/M ratio 
was calculated for both strains and found to be significantly decreased in scp160 samples  
(2.6 ± 0.47 in scp160 versus 4.3 ± 0.08 in wildtype) (Fig. 18). These values reflect an increase in 
the monosome peak and a decrease in the polysome peaks of scp160 cells, which is indicative of 
a defect in translation initiation. Yet, further experiments indicated that this initiation defect 
constitutes an indirect or long#term effect of Scp160 loss (see next section).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18. scp160I cells are impaired in translation initiation. Lysates of wildtype (RJY358) and scp160@ 
(RJY3178) cells were separated on 20#60% linear sucrose gradients, and gradient fractions were collected 
from top to bottom with continuous UV absorption measurement at 256 nm. From the recorded profiles, 
polysome (P) and monosome (M) areas were defined. Polysome#to#monosome ratios (P/M) report the 
global translation state. Data represent averages of three independent experiments; standard deviations are 
indicated in brackets. 
 
4.4. A Tetoff system for the efficient depletion of Scp160 
As described in the previous section, scp160 deleted cells display reduced fitness, increased 
sensitivity against translation inhibitors, and reduced polysome#to#monosome ratios. These 
findings suggest a participation of Scp160 in translational processes. However, since deletion of 
Scp160 causes alterations in ploidy (Wintersberger et al., 1995), I was worried that these results 
are due to secondary effects caused by ploidy changes. Therefore, I generated a yeast strain in 
which SCP160 expression is under control of a repressible Tetoff operator, which allows rapid 
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depletion of the protein upon addition of doxycycline (Gari et al., 1997). As verified by Western 
blot, repression of SCP160 resulted in a considerable reduction of the protein after three hours 
(Fig. 19A). The protein was undetectable after five hours of depletion. In order to test if ploidy 
alterations occur during or directly after depletion, DNA content was determined by FACS 
analysis. FACS profiles of Tetoff::SCP160 cells were recorded after 6, 12, 18, and 24 hours of 
Scp160 depletion and compared to the FACS profile of scp160∆ cells (Fig. 19B). A population of 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Depletion of Scp160 results in an increase of ploidy, but does not affect global translation. 
(A) Western blot of a depletion time course. Logarithmically growing strain RJY3180 was incubated with 
2 Vg/ml doxycycline 6 h in total. At times indicated, aliquots were removed to prepare cell extracts. 
Equivalent protein amounts were used for Western blotting. Depletion of Scp160 was monitored by 
probing the blot with an anti Scp160 antibody, actin served as loading control. (B) FACS analysis of 
Scp160#depleted cells. During a time course of 24 h, 2 OD600nm units of cells were removed every 6 h, 
fixed and prepared for FACS analysis. An scp160 strain served as control. DNA contents corresponding 
to the haploid (1n), diploid (2n) or tetraploid (4n) state are indicated. (C) Global translation is not 
impaired by depletion of Scp160. Cell extracts were prepared of non#depleted and Scp160#depleted cells 
and separated by sucrose density centrifugation. Polysome#to#monosome ratios (P/M) were calculated as 
in Fig. 18. Data represent averages of three independent experiments; standard deviations are indicated in 
brackets. 
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haploid scp160∆ cells does not only contain cells with 1n or 2n DNA content but in addition 4n 
cells, indicating a failure to faithfully control ploidy. In contrast, only very few 4n cells can be 
detected in a population of cells depleted for Scp160 for six hours. I therefore chose a six hour 
depletion period of Scp160 for my further experiments. 
Using the newly established depletion system, I repeated the polysome profile analyses (see 
section 4.3.2.). Polysome#to#monosome ratios were calculated and found to be unchanged by 
depletion of Scp160 (control: 3.7 ± 0.58, depletion: 3.5 ± 0.37; Fig. 19C). In conclusion, Scp160 
does not directly affect global translation initiation.  
 
4.5. Translational profiling – elucidating the function of Scp160 in 
translation 
Translational activity of a given transcript is commonly measured as the extent of its association 
with polysomes. As mentionend above, sucrose density gradient centrifugation can be used to 
separate cell extracts in translationally inactive or less active fractions (containing mRNPs, 
ribosomal subunits and monosomes; "light") and in fractions with high translational activity 
(polysomes; "heavy"). Using microarray analysis, specific translational profiles can be assigned to 
all mRNAs present in the samples. A large number of genome#wide studies dealing with the 
effects of diverse treatments such as glucose starvation or application of rapamycin have shown 
that this approach is highly valuable to identify both global translational changes as well as 
changes limited to smaller mRNA subsets (reviewed in Halbeisen et al., 2008). Therefore, I 
decided to apply a similar approach with the aim to identify transcripts that are differentially 
translated in dependence on Scp160.  
The experimental setup comprised two parts. First, I aimed at identifying transcripts with changes 
in their translation rates and second, I wanted to assess genome#wide steady#state mRNA levels. 
The latter is essential for the interpretation of translation rate changes since reduced association 
of mRNAs with non#translating gradient fractions could either result from a shift towards 
translationally more active fractions or from increased degradation (Melamed & Arava, 2007). 
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Fig. 20. Workflow of the translational profiling approach. Extracts from Scp160#depleted and non#
depleted (control) cells were prepared and either directly used for isolation of total RNA (right) or 
fractionated by sucrose density centrifugation (left). RNA was extracted from fraction pools 
corresponding to mRNPs, ribosomal subunits and monosomes (light fractions) and heavy polysomes 
(heavy fractions). RNA samples were reverse transcribed and hybridized to DNA microarrays. Whereas 
analysis of total RNA should reveal changes in overall transcription and RNA stability, analysis of 
translationally inactive (light) and active (heavy) gradient fractions should reflect the translational state of 
the mRNAs.  
 
A scheme of the experimental setup that was applied in this study is shown in Fig. 20. In order to 
prevent secondary effects caused by deletion of Scp160, I used cells in which Scp160 was 
depleted for 6 h by the above described Tetoff system (section 4.4.); mock#depleted cultures 
served as negative control. Whole cell extracts were prepared as described in section 6.2.5.1. and 
used for preparation of total RNA as well as for sucrose density centrifugation with subsequent 
RNA isolation from light and heavy fractions. Following reverse transcription, cDNA was 
hybridized to DNA microarrays. Data analysis was done in cooperation with Andreas Mayer 
from Prof. Patrick Cramer's laboratory at the Gene Center, LMU Munich. 
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4.5.1. Depletion of Scp160 causes subtle changes at the transcriptome level 
To determine if loss of Scp160 leads to changes in the abundance of specific mRNAs, either 
through differing stability or changed transcription rates, microarray analyses were performed of 
total RNA from control and Scp160#depleted cells (see Fig. 20).  
Using a standard p#value cutoff of 0.05 and a conservative fold change threshold of 2.5 in order 
to minimize the occurence of false positives, I identified 60 mRNAs of which 49 were down# and 
11 were up#regulated (see table 1). With a fold change threshold of 2.0, the abundance of 117 
mRNAs was affected (89 down# and 28 up#regulated). This corresponds to 1.1% and 2.1% of the 
yeast transcriptome, respectively. Notably, most transcripts showed a decreased abundance in 
absence of Scp160 (82% and 76%, respectively). Among the five most downregulated mRNAs 
was SCP160 (fold change of 0.11, corresponding to a 9#fold decrease compared to control cells), 
confirming the efficiency of the depletion. Li and coworkers identified YOR338W mRNA as 
being associated with Scp160#containing complexes, and found it to be 2.5#fold more abundant 
in scp160 cells as in wildtype (Li et al., 2003). In my study, I measured a 2.9#fold increased level 
of YOR338W upon depletion of Scp160, indicating that direct targets of Scp160 are likewise 
affected by deletion and depletion of Scp160.  
 
 
Table 1. List of genes that are significantly up# or downregulated upon depletion of Scp160. Threshold: 
2.5#fold change (≥ 2.5 or ≤ 0.4); data from duplicate microarray and qRT#PCR analysis. 
 
ORF Symbol Fold change (depl. vs. control) pvalue 
Fold change (depl. vs. control) 
qRTPCR 
YCR021C* HSP30 0.04 4.05e#05 n/a 
YER067W ### 0.05 2.10e#04 n/a 
YER053C#A ### 0.10 1.49e#05 n/a 
YPL014W ### 0.11 1.58e#06 n/a 
YJL080C* SCP160 0.11 2.13e05 0.07 
YDR171W* HSP42 0.13 1.91e#05 0.92 
YNR034W#A ### 0.14 6.38e#04 n/a 
YER053C PIC2 0.17 1.18e#05 n/a 
YJL144W ### 0.18 5.27e#04 n/a 
YER150W SPI1 0.19 1.41e#05 n/a 
YHR087W ### 0.21 6.21e#04 n/a 
YFR015C GSY1 0.23 1.67e#04 n/a 
YHL036W* MUP3 0.23 1.06e#06 0.95 
YBR054W* YRO2 0.24 1.15e#04 0.89 
YPR157W ### 0.24 1.93e#04 n/a 
YLL026W* HSP104 0.25 1.26e#03 0.89 
YGR249W* MGA1 0.25 9.43e#04 0.83 
YGR008C STF2 0.26 1.26e#03 n/a 
YMR104C YPK2 0.27 2.66e#03 n/a 
YLR327C* TMA10 0.28 1.12e#03 1.01 
YJL052W ### 0.28 8.97e#05 n/a 
YGR052W ### 0.28 1.60e#04 n/a 
YGR248W SOL4 0.29 4.35e#04 n/a 
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YOR273C TPO4 0.29 7.53e#04 n/a 
YMR081C ISF1 0.30 1.20e#03 n/a 
YMR250W GAD1 0.30 2.07e#04 n/a 
YHL021C ### 0.30 1.93e#03 n/a 
YEL011W GLC3 0.30 4.97e#04 n/a 
YDR258C HSP78 0.31 5.47e#04 n/a 
YJL052W ### 0.32 3.52e#04 n/a 
YGR142W BTN2 0.33 2.58e#04 n/a 
YOR134W BAG7 0.33 4.95e#04 n/a 
YLR297W ### 0.33 3.06e#05 n/a 
YCL040W GLK1 0.34 1.32e#04 n/a 
YPL240C* HSP82 0.34 1.18e#03 0.96 
YML128C MSC1 0.34 1.10e#04 n/a 
YBR214W SDS24 0.35 7.63e#04 n/a 
YLR142W PUT1 0.35 1.80e#03 n/a 
YER037W PHM8 0.35 1.58e#04 n/a 
YMR084W ### 0.36 2.51e#02 n/a 
YBR169C* SSE2 0.36 1.61e#04 0.77 
YBR183W YPC1 0.36 1.56e#04 n/a 
YOR178C GAC1 0.36 8.91e#03 n/a 
YGR088W CTT1 0.39 1.98e#03 n/a 
YCR005C CIT2 0.39 4.59e#05 n/a 
YDR222W ### 0.39 8.83e#04 n/a 
YOR173W* DCS2 0.39 2.48e#03 0.79 
YER130C ### 0.39 2.71e#05 n/a 
YJL133C#A ### 0.39 4.26e#03 n/a 
YMR085W ### 0.40 3.14e#04 n/a 
YBR105C VID24 2.53 1.29e#04 n/a 
YBR296C PHO89 2.55 4.75e#03 n/a 
YDL038C ### 2.64 2.41e#03 n/a 
YOL154W ZPS1 2.76 8.23e#04 n/a 
YOR338W ### 2.90 5.95e#04 n/a 
YNL065W AQR1 2.98 1.93e#04 n/a 
YDL037C BSC1 3.13 2.87e#03 n/a 
YGR079W ### 3.14 8.13e#04 n/a 
YGL209W MIG2 3.34 7.68e#05 n/a 
YKR075C ### 3.94 2.05e#04 n/a 
YGR035C ### 6.15 1.50e#04 n/a 
mRNAs subsequently tested by qRT#PCR are marked with a star (*). n/a – not tested. 
 
Functional and locational classification of the proteins encoded by mRNAs with a more than  
2.5#fold change was performed using the MIPS Functional Catalogue Database (Ruepp et al., 
2004). With a p#value cutoff of 0.05 and considering only categories to which at least five mRNA 
targets could be assigned, I found a significant enrichment of transcripts encoding proteins that 
are localized to vacuole and cytoplasm (Fig. 21, upper panel). Regarding functional terms, 
mRNAs that code for proteins with functions in protein folding and stabilization, stress response 
and energy metabolism were overrepresented (p#value ≤ 0.005, at least five mRNAs; Fig. 21, 
lower panel). These data suggest that depletion of Scp160 induces stress#related changes in the 
transcriptome. 
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Fig. 21. Depletion of Scp160 induces changes in the abundance of stressrelated mRNAs. Proteins 
encoded by mRNAs which are up# or downregulated more than 2.5#fold upon depletion of Scp160 were 
classified using the MIPS Functional Catalogue Database. Upper panel: Locational distribution analysis 
revealed an enrichment of vacuolar and cytoplasmic proteins (p#value cutoff:  
p ≤ 0.05). Lower panel: Functional distribution analysis showed enrichment in distinct subgroups (p#value 
cutoff: p ≤ 0.005). 
 
In order to confirm the data derived from the microarrays, I performed qRT#PCR on control and 
Scp160#depleted samples for ten of the candidate mRNAs. Although downregulation of SCP160 
itself was in a similar range as measured by microarray analysis (microarrays: 9#fold decreased, 
qRT#PCR: 14#fold decreased), I could not corroborate the changes of the other transcripts tested 
(see table 1). This indicates that the data set gained from microarray analysis contains a high 
percentage of false#positives, probably due to the limited number of replicates (duplicate 
analysis). Deeper analysis of transcripts whose abundance is affected by loss of Scp160 was 
beyond the scope of this work since my focus was on Scp160's function in translational control. 
Careful validation by qRT#PCR of the so far not tested target mRNAs would be essential for 
potential further studies focusing on transcriptome changes induced by Scp160. 
 
4.5.2. Depletion of Scp160 induces translational state changes of a subset of 
mRNAs 
As described above, microarray analysis of RNAs isolated from translationally active and inactive 
gradient fractions was carried out to determine if depletion of Scp160 induces changes in the 
translational activity of specific mRNAs. From the resulting dataset, translational state changes 
were calculated (Fig. 22). I defined the translational state of an mRNA as the ratio of its 
abundance in heavy versus light fractions. The translational state of each mRNA was registered in 
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Scp160#depleted and control cells. From these values, ratios were calculated to obtain a 
translational state change (TSC) that reflects the shift in the distribution of a given mRNA within 
the sucrose gradient upon depletion of Scp160. Increases of the TSC value should indicate a shift 
from less efficient to efficient translation, whereas decreased TSC values should indicate an 
opposite shift. Using a cutoff of 1.8#fold (≥ 1.8 or ≤ 0.56), I identified 48 mRNAs with increased 
and 12 mRNAs with decreased polysome association (Table 2; 2 fold cutoff: 23 and 5 mRNAs, 
respectively). These results indicate that depletion of Scp160 affects the translational state of a 
small subset of mRNAs (1.1% of the transcriptome) even before ploidy defects are detectable. 
Notably, the majority (80%) of these mRNAs were shifted towards the heavy gradient fractions, 
indicating that Scp160 has the same effect on the translation of this group of targets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22. Calculation of translation state changes. Sucrose gradient profiles of whole cell extracts of 
Scp160#depleted and control samples were monitored by absorbance at 256 nm. The positions of the 
small and large ribosomal subunits (* # 40S, ** #  60S), monosomes and polysomes are indicated. Light and 
heavy fractions of both samples were collected, and extracted mRNA was used for duplicate microarray 
analyses. For each individual mRNA, translation states were calculated as the ratio of the normalized 
signal in heavy and light fraction. Translation state changes were then calculated as the double ratio of the 
translation states in Scp160#depleted versus control sample.   
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Table 2. Genes with significant (≥ 1.8 or ≤ 0.56) translation state changes (TSC) upon depletion of 
Scp160 (data from duplicate microarray analyses). 
 
ORF Symbol 
TSC 
depleted/controla 
Polysomal RNA 
depleted/controlb 
Monosomal RNA 
depleted/controlc 
Total RNA 
depleted/controlb 
YPR159C#A ### 3.71 1.43 0.43 1.02 
YHR213W ### 2.67 1.95 0.74 1.07 
YJL078C* PRY3* 2.66* 2.08* 0.75* 0.97* 
YCR089W FIG2 2.60 1.83 0.76 1.43 
YLR139C SLS1 2.60 2.08 0.82 1.43 
YAL065C ### 2.59 1.57 0.65 1.12 
YJR151C DAN4 2.42 1.73 0.75 0.99 
YNR044W* AGA1* 2.41* 2.17* 0.93* 1.37* 
YHR189W PTH1 2.40 1.66 0.76 1.02 
YCL021W#A ### 2.29 1.87 0.89 1.21 
YDR420W HKR1 2.23 2.23 0.97 1.14 
YIR019C MUC1 2.21 1.67 0.82 1.03 
YPL085W SEC16 2.18 1.57 0.74 1.15 
YLR337C VRP1 2.17 1.83 0.90 0.91 
YNL271C BNI1 2.17 1.71 0.83 1.06 
YLR013W GAT3 2.15 1.41 0.70 1.02 
YMR175W#A ### 2.10 1.42 0.65 1.03 
YAR050W FLO1 2.09 1.58 0.77 1.03 
YAR009C ### 2.07 2.27 1.10 0.89 
YJL216C ### 2.05 1.34 0.65 1.38 
YKR102W FLO10 2.05 1.49 0.76 1.24 
YOR181W LAS17 2.01 1.52 0.78 1.05 
YBL074C AAR2 2.01 1.52 0.74 1.19 
YOL019W#A ### 2.00 1.08 0.58 1.02 
YMR070W MOT3 1.97 1.71 0.93 1.45 
YLR315W NKP2 1.95 1.15 0.59 0.83 
YOR316C#A ### 1.95 1.35 0.65 1.11 
YBR072C#A ### 1.94 1.19 0.58 1.01 
YNL277W#A ### 1.94 1.10 0.57 0.79 
YNL068C FKH2 1.91 1.65 0.88 1.05 
YCR108C ### 1.91 1.20 0.62 0.97 
YDL039C PRM7 1.90 1.72 0.93 2.44 
YCR068W ATG15 1.90 1.56 0.87 0.97 
YER132C PMD1 1.89 1.49 0.84 1.15 
YGR023W MTL1 1.88 1.87 1.03 0.57 
YBL044W ### 1.87 1.09 0.57 1.10 
YNL093W YPT53 1.87 1.03 0.58 0.49 
YEL035C UTR5 1.85 1.31 0.70 1.13 
YLR390WA* CCW14* 1.84* 0.98* 0.56* 1.02* 
YNL034W ### 1.84 1.26 0.69 1.26 
YLR393W ATP10 1.83 1.23 0.68 1.12 
YDL195W SEC31 1.83 1.34 0.74 1.02 
YEL019C MMS21 1.82 1.16 0.63 0.99 
YLR136C TIS11 1.82 1.27 0.72 0.56 
YOR394C#A ### 1.81 1.54 0.85 1.20 
YOR329C SCD5 1.81 1.42 0.81 0.96 
YGR014W* MSB2* 1.81* 1.74* 0.99* 1.12* 
YGR249W MGA1 1.80 1.38 0.69 0.25 
YDR034C#A ### 0.55 0.47 0.61 1.16 
YGR109W#A ### 0.55 0.72 1.12 1.21 
YDL156W ### 0.55 0.84 1.22 0.99 
YFL024C EPL1 0.52 1.05 1.62 1.12 
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YFL068W ### 0.52 0.61 1.15 1.14 
YER014C#A BUD25 0.52 0.52 0.79 1.05 
YIR018C#A ### 0.51 0.48 0.74 1.14 
YGL168W HUR1 0.47 0.46 0.86 1.23 
YFR035C ### 0.47 0.42 0.62 1.03 
YGR240C#A ### 0.46 0.45 0.70 1.27 
YGR035W#A ### 0.45 0.49 0.90 1.86 
YDR524W#A ### 0.36 0.31 0.50 1.36 
mRNAs tested by IP#qRT#PCR are in bold; mRNAs associated with Scp160 are marked with a star. 
a Changes in translation state (heavy/light (D) / heavy/light (C)) 
b Changes in polysomal mRNA pool 
c Changes in monosomal and mRNP associated mRNA pool 
d Changes in total mRNA pool 
 
A systematic classification of the mRNAs up# or downregulated in translation revealed that they 
are enriched for mRNAs encoding extracellular and cell wall proteins, as well as proteins involved 
in ER#to#golgi transport (Fig. 23, upper panel) as classified by the MIPS Functional Catalogue 
Database (Ruepp et al., 2004). The targets can be functionally grouped into proteins involved in 
cell#cell adhesion, cell polarity establishment and filament formation, sugar binding, endocytosis, 
and response to osmotic and salt stress (Fig. 23, lower panel). A common feature of many of 
these proteins is their targeting to the ER which occurs mainly co#translationally. This is in 
agreement with previously published data showing that Scp160 localizes to cytoplasmic as well as 
ER#attached polysomes (Frey et al., 2001; Weber et al., 1997; Lang & Fridovich#Keil, 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23. Depletion of Scp160 changes translational states of a specific set of mRNAs. mRNAs with 
significant translation state changes (≥ 1.8 or ≤ 0.56) upon depletion of Scp160 were classified using the 
MIPS Functional Catalogue Database. Upper panel: Locational distribution analysis of the proteins 
encoded by the candidate mRNAs revealed clustering in specific classes (p#value cutoff: p<1.5e#02). 
Lower panel: Functional distribution analysis of the same proteins showed enrichment in distinct 
subgroups (p#value cutoff: p<4.0e#03). 
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4.6. mRNAs with significant translational state changes are bound by 
Scp160 
4.6.1. Target mRNAs are enriched in immunoprecipitates of Scp160 
The observed changes of the translational state of some mRNAs could be a direct consequence 
of the loss of Scp160, e.g. if it functions as translational regulator, or indirect by affecting the 
overall physiological state of the cell. A direct function on its target mRNAs is likely to be 
mediated by the RNA#binding activity of Scp160. In order to test this assumption, I applied 
immunoprecipitation of C#terminally myc9#tagged Scp160 in combination with quantitative  
real#time PCR (qRT#PCR) to detect co#purifying RNAs (Fig. 24). As specificity controls, I 
performed the same assay with two additional RNA#binding proteins that were likewise tagged 
with nine myc epitopes. She2 is an RNA#binding protein that associates with a defined set of 
localized mRNAs (Shepard et al., 2003). Khd1, like Scp160, belongs to the group of KH domain 
containing RNA#binding proteins and binds to a large set of mRNAs with diverse functions (Irie 
et al., 2002; Hogan et al., 2008; Hasegawa et al., 2008). Myc#tagged versions of all three proteins 
were functionally expressed in yeast and Western blot analysis confirmed that similar amounts of 
each protein could be immunoprecipitated (Fig. 24A). RNA was extracted from the pellet, 
reverse transcribed, and amplified with primers against 14 mRNAs showing significant 
translational state changes (≥ 1.8 or ≤ 0.56), but no differences in their total abundance (≥ 0.71, 
≤ 1.4; see table 2). I also included the nucleoporin#encoding POM34 transcript in my analysis 
since it has recently been identified as a target of Scp160 (Sezen et al., 2009). Fig. 24B 
summarizes the results for the four mRNAs with significant enrichment in the Scp160 
immunoprecipitates. Whereas She2 co#immunoprecipitated its known target mRNA ASH1 but 
none of the other five mRNAs (Fig. 24B, black bars), Scp160 immunopellets (Fig. 24B, blue bars) 
were >7 fold enriched for CCW14, AGA1 and PRY3 and >2 fold enriched for MSB2 and 
POM34 mRNAs. These enrichment values do not directly reflect the degree of the translation 
state changes of these transcripts, since the TSCs of AGA1 and PRY3 are 2.4 and 2.7, 
respectively, whereas both CCW14 and MSB2 have a TSC of 1.8. A control mRNA, CFT1, whose 
translation rate did not change upon Scp160 depletion, neither co#purified with Scp160 nor with 
She2. AGA1, PRY3, and POM34 were enriched in Khd1 immunopellets at similar levels (Fig. 24, 
orange bars), suggesting that they contain binding sites for KH domain type RNA#binding 
proteins. CCW14 and MSB2 mRNAs were also associated with Khd1, albeit enrichment was 
reduced in comparison to the Scp160 immunopellets to approximately 37% and 78%, 
respectively (p#values < 0.05). In summary, out of the 14 candidate mRNAs I found four to be 
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Fig. 24. Scp160 physically associates with target mRNAs. (A) Western blot of the 
immunoprecipitation of myc9#tagged Scp160 (strain RJY3515), Scp160 truncated for KH domains 13 and 
14 (RJY3516), She2 (RJY3512) and Khd1 (HSY15) using anti myc antibody. T # total extracts, FT # 
flowthrough, IP # immunoprecipitate. (B) Scp160 binds CCW14, AGA1, PRY3, POM34 and MSB2 
mRNAs. Immunoprecipitates were subjected to qRT#PCR and analyzed for bound ASH1 mRNA 
(positive control in She2 IP), CFT1 mRNA (negative control), and candidate mRNAs CCW14, AGA1, 
PRY3, MSB2 and POM34. Specific enrichment was calculated as ratio of the signal in the target IP to the 
mock IP (untagged wildtype strain). Statistical significance (Student’s t#test) compared to the KH domain 
truncation is indicated: *, P < 0.05; **, P < 0.01. Data are presented as mean ± standard deviation, n = 3. 
 
 
enriched more than 2#fold in the Scp160 immunoprecipitates (Fig. 24B): CCW14, encoding a cell 
wall glycoprotein (Moukadiri et al., 1997), AGA1 that codes for a subunit of a#agglutinin in the 
cell wall (Roy et al., 1991), PRY3 that encodes a member of the PRY family of GPI#anchored cell 
wall proteins (Yin et al., 2005), and MSB2, coding for an integral plasma membrane mucin linked 
to osmosensing (O'Rourke & Herskowitz, 2002). Consistently, these four mRNAs were also 
identified as associated with Scp160 (log2 ≥ 1.1) in a recent large#scale survey (Hogan et al., 
2008).  
To investigate if binding of Scp160 to the mRNAs mentioned above is direct or mediated by an 
associated protein, I generated a carboxyterminally truncated version of Scp160 that lacks the last 
two KH domains (Scp160∆KH13/14). Myc9#tagged Scp160∆KH13/14 can be immuno#
precipitated at similar levels than the full#length protein (Fig. 24A). However, none of the 
mRNAs co#purifying with Scp160 associates with the truncated version (Fig. 24B, light green 
bars), indicating that the last two KH domains are essential for RNA binding.  
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4.6.2. Conserved residues in KH domains 13 and 14 are essential for target 
RNA binding 
In section 4.2.2., the generation of Scp160 point mutants with amino acid exchanges in the 
conserved RNA binding pockets of KH domains 13 and 14 has been described. These mutant 
versions of Scp160 have been shown to still localize to the ER and ribosomal fractions in 
subcellular fractionation experiments, but they are in addition present in a free, non#ribosome 
associated cytoplasmic pool (see Fig. 12). In order to obtain evidence that these point mutations 
are deleterious for RNA binding, I tested them in the above#described IP#qRT#PCR assay. Both 
mutants (either containing mutations in KH domain 14 only or additionally in KH domain 13; 
refer to Fig. 12) could be immunoprecipitated with similar efficiency as wildtype myc9#tagged 
Scp160 expressed from the same low copy vector (Fig. 25A). qRT#PCR revealed that 
Scp160mutKH14 binds significantly less of CCW14, AGA1, and PRY3 mRNAs (Fig. 25B, blue 
bars) and that mutation of KH13 and KH14 (light green bars) reduces binding to less than 50% 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25. Conserved residues in KH domains 13 and 14 are essential for target RNA binding.  
(A) Western blot of the immunoprecipitation of myc9#tagged Scp160 (HSY11), Scp160 with point 
mutations in KH domain 14 (HSY10) and Scp160 with point mutations in KH domains 13 and 14 
(HSY12) using anti#myc antibody. As control, a strain expressing untagged wildtype Scp160 from pRS316 
was used. T: total extracts, FT: flowthrough, IP: immunoprecipitate. (B) Target RNA binding of Scp160 
point mutants is impaired. Immunoprecipitates of plasmid#derived myc9#tagged Scp160 (HSY11), 
Scp160mutKH14 (G1170D and G1173D) (HSY10) and Scp160mutKH13/14 (additionally G1028D and 
I1031N) (HSY12) were subjected to qRT#PCR and analyzed for bound CCW14, AGA1, PRY3 and MSB2. 
Specific enrichment was calculated as in Fig. 24 and plotted as relative binding (target binding of wildtype 
Scp160#myc9 was arbitrarily set to 1). Data are presented as mean ± standard deviation, n = 2. 
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of the wildtype. We conclude that mutations in amino acids that have been implicated in RNA 
binding by KH domains reduce the affinity of Scp160 for at least three mRNAs whose 
translational state depends on this protein. These mRNAs therefore represent likely target 
mRNAs for Scp160. 
 
4.7. Scp160 is required for efficient translation of PRY3 mRNA 
So far, I have shown that PRY3 mRNA significantly shifts towards the polysome fraction in 
response to depletion of Scp160 (section 4.5.2.), and that it is directly associated with Scp160 via 
KH domains 13 and 14 (sections 4.6.1. and 4.6.2.). My next experiments addressed the question if 
the gradient shift of PRY3 indeed affects its translation rate.  
 
4.7.1. Pry36HA protein levels are reduced in cells lacking Scp160 
In order to test if the observed translational state changes reflect altered translation, I determined 
Pry3 levels before and after Scp160 depletion. For detection of Pry3, a variant with six HA 
epitopes fused to the carboxyterminus was expressed from its genomic locus. Lysates were 
prepared from cells six hours after doxycycline addition or after six hours incubation without 
 
 
 
 
 
 
  
 
Fig. 26. Pry36HA protein levels are reduced upon depletion of Scp160. Whole cell extracts were 
prepared from strain RJY3498 6 h after addition of 2 Vg/ml doxycycline or after mock depletion. Left 
panel: Equivalent total protein amounts were used for Western blotting. Probing with anti Scp160 
antibody shows the efficient depletion of Scp160, anti HA antibody the reduction of Pry3#6HA protein 
levels upon depletion of Scp160, and Pgk1 serves as loading control. One representative experiment is 
shown. Middle panel: Quantification of four experiments performed as in the left panel. Right panel: RNA 
was prepared from the same samples and used for qRT#PCR. Relative PRY3 and SCP160 mRNA levels 
were calculated as signal ratio between Scp160#depleted and non#depleted samples. All data are presented 
as mean ± standard deviation, n = 4.  
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doxycycline (mock depletion). In contrast to Scp160 or phosphoglycerokinase (Pgk1), no defined 
bands but a smear at >200 kDa could be detected for Pry3#6HA (Fig. 26, left panel). Depletion 
of Scp160 led to a reduction of Pry3 levels to 66% (+/#11%) (Fig. 26, middle panel; four 
independent depletion experiments). In contrast, PRY3 mRNA levels did not significantly 
change, whereas SCP160 mRNA dropped to 6% (+/# 3%) of the original amount (Fig. 26, right 
panel). However, quantification of the protein levels was hampered by the smeary Western blot 
signal for Pry3, which was presumably caused by its GPI anchor (Eisenhaber et al., 2004). 
 
4.7.2. Pry3GPI protein levels are reduced upon loss of Scp160 
To obtain more focused Pry3 signals on Western blots and therefore allow for more reliable 
quantification, I replaced the C#terminal 29 amino acids that include the GPI modification site at 
Gly 853 (Fig. 27A) as predicted by the GPI Fungal Prediction Server (Eisenhaber et al., 2004) by 
a myc9 tag (Pry3∆GPI#myc9). FACS analysis demonstrated that this truncated version of Pry3 
induced only minor changes in the DNA content of the resulting yeast strain (Fig. 27B), in 
contrast to the depletion of Pry3 (refer to Fig. 30). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27. Pry3 has a predicted GPI modification site. (A) Schematic drawing of the Pry3 primary 
structure illustrating the position of the predicted signal peptide (aa 1#18, shown in green), propeptide  
(aa 854#881, marked in red) and GPI modification site (Gly853). Refer to UniProtKB/Swiss#Prot data 
base entry P47033. Figure drawn to scale. (B) FACS analysis of the PRY3∆GPImyc9 strain (HSY19) 
reveals only minor DNA content aberrations. 
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Removal of the GPI modification site expectedly resulted in a more focused signal of Pry3, 
allowing better quantification (Fig. 28A and 28B, left panels). Pry3∆GPI#myc9 levels in scp160 
were reduced to 53% (+/# 7%) compared to the wildtype control (Fig. 28A, middle panel). In 
cells depleted for Scp160, Pry3∆GPI#myc9 levels decreased to 87% (+/#12%; student's t#test: p 
= 0.0022) compared to non#depleted controls (Fig. 28B, middle panel). In both experimental 
setups, mRNA levels did not drop accordingly (Figs. 28A and 28B, right panels), suggesting a 
decrease in Pry3 translation or an increase in Pry3 degradation upon loss of Scp160.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. Pry3GPI protein levels are reduced upon loss of Scp160. (A) Whole cell extracts were 
prepared from strain HSY19 (Pry3GPI#myc9 in WT background) and four independent clones of strain 
HSY20 (Pry3GPI#myc9 in scp160 knock#out background). Left panel: Western blot of one 
representative experiment. Middle panel: Quantification of three independent experiments carried out as 
in the left panel. Right panel: RNA was prepared from the same strains and used for qRT#PCR. Relative 
PRY3(GPI mRNA levels are represented as the signal ratio between scp160 and WT background.  
(B) Pry3GPI levels in Scp160#depleted cells. Whole cell extracts were prepared from strain HSY21 6 h 
after addition of 2 Vg/ml doxycycline or after mock depletion. Left panel: Representative Western blot 
showing the efficient depletion of Scp160 (anti Scp160) and the reduction of Pry3GPI#myc9 protein 
levels upon depletion of Scp160 (anti myc). Pgk1 serves as loading control. Middle panel: Quantification 
of n = 11 experiments performed as in the left panel. The decrease of the Pry3GPI#myc9 protein levels 
in the sample depleted for Scp160 is highly significant (Student’s t#test, p = 0.0022). Right panel: RNA 
was prepared from the same samples and used for qRT#PCR. Relative PRY3 and SCP160 mRNA levels 
were calculated as the signal ratio between the Scp160#depleted and non#depleted samples. All data are 
presented as mean ± standard deviation, n = 3.  
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4.7.3. Enhanced degradation is not responsible for reduced levels of Pry3 
protein 
To rule out that enhanced degradation upon loss of Scp160 is responsible for the reduction in 
Pry3 protein levels, I performed cycloheximide chase experiments to determine the half#life of 
Pry3∆GPI#myc9 in Scp160#depleted, scp160∆, and control cells. Western blotting against 
Pry3∆GPI#myc9 in lysates from cells that had been incubated with the translation inhibitor 
cycloheximide (CHX) demonstrated that the decay of Pry3∆GPI#myc9 is not accelerated after 
Scp160 depletion. Half#lives of Pry3∆GPI#myc9 in scp160∆ or Scp160#depleted cells (t1/2=8 min 
or 11 min, respectively) were not significantly reduced as compared to wildtype (t1/2 = 7 min) or 
mock#depleted (t1/2 = 14 min) cells (Fig. 29). In conclusion, these data confirm that enhanced 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29. Stability of Pry3∆GPImyc9 is not affected in cells lacking Scp160. Cycloheximide (CHX) 
chase analyses were performed to assess the stability of Pry3∆GPI#myc9 in wildtype (HSY19), scp160∆ 
(HSY20) and Scp160 depletion (HSY21) background. Logarithmically growing cultures were 
supplemented with 0.5 mg/ml CHX; aliquots were taken at indicated time points and immediately 
processed for Western blotting. Upper panels: Representative Western blots probed with either anti#myc 
antibody to detect Pry3∆GPI#myc9 or anti Scp160 and anti Pgk1 antibodies to test for successful 
depletion of Scp160. Lower panel: Quantification of five replicates (Scp160 depletion) and three replicates 
(WT versus scp160∆). Data are presented as mean ± standard deviation. 
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degradation is not the cause for the reduced Pry3 protein levels. It is therefore likely that Scp160 
causes translational downregulation of Pry3, which suggests that Scp160 is required for proper 
translation of this GPI#anchored protein. 
 
4.8. Depletion of PRY3 triggers polyploidization 
A hallmark of scp160∆ cells is an increased ploidy in a subpopulation of these cells 
(Wintersberger et al., 1995). Since Scp160 is an RNA#binding protein, the defect in ploidy control 
could be due to translational misregulation of one or several of its target mRNAs. Among the 
four mRNAs that I confirmed to directly bind to Scp160 (see sections 4.6.1. and 4.6.2.), PRY3 
mRNA is the one with the strongest translational state change (2.7; see table 2). As demonstrated 
in chapter 4.7, efficient translation of PRY3 mRNA requires Scp160. Therefore, I asked if a 
decrease in the Pry3 level results in polyploidization.  
A strain for the galactose#inducible expression of PRY3 was constructed by replacing the 
endogenous PRY3 pomoter by the GAL1 promoter. When pGAL17PRY3 cells were grown under 
repressing conditions, PRY3 mRNA levels dropped to 21% of wildtype levels as measured by 
qRT#PCR (Fig. 30). Most interestingly, loss of Pry3 was associated with an increase of the 
subpopulation of haploid cells with 4n DNA content, which is reminiscent of the FACS profile 
of scp160∆ cells (Fig. 30).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30. Depletion of PRY3 mRNA induces polyploidization. Left panel: qRT#PCR analysis of 
relative PRY3 mRNA levels in uninduced GAL7PRY3 cells (RJY3487) compared to wildtype (RJY358) 
indicates a reduction to 21%. Right panel: FACS analysis of the same sample reveals a significant fraction 
of cells with tetraploid DNA content similar to the scp160 (RJY3178) phenotype. 
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To test if overexpression of Pry3 also induces ploidy changes, I introduced a plasmid harboring 
the PRY3 ORF under control of the inducible GAL1 promoter into a wildtype strain that still 
contained an intact PRY3 copy. In contrast to the depletion of PRY3, induction of its 
overexpression by growth in galactose#containing medium did not effect any changes in ploidy, 
as determined by FACS analysis (not shown). 
 
4.9. Overexpression of Pry3 does not rescue the polyploidy phenotype 
of scp160 deletion strains 
In the last sections, I showed that loss of Scp160, which goes along with ploidy increase, causes a 
reduction of Pry3 protein levels, and that depletion of PRY3 equally induces polyploidization. 
Therefore, Pry3 is a likely candidate of an Scp160#controlled factor that regulates ploidy. 
In order to test if depletion of Pry3 is the major cause of ploidy misregulation, I performed 
rescue experiments. Pry3 was expressed in scp160∆ cells from a plasmid with the strong 
constitutive GPD1 promoter to determine if Pry3 overexpression reverts the polyploidization 
phenotype in scp160∆ cells. Although expression of Pry3 from the GPD1 promoter resulted in 
>50 fold increase of PRY3 mRNA, the number of cells with 4n content in an scp160∆ GPD7
PRY3 strain were not reduced as compared to scp160∆ (Fig. 31). This suggests that correct 
translation of PRY3 is required for ploidy regulation but that it is not the only target of Scp160 
whose misregulation ultimately leads to polyploidization. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31. Overexpression of Pry3 does not rescue the polyploidy phenotype of scp160∆ cells. Left 
panel: qRT#PCR analysis demonstrating 50#fold overexpression of PRY3 under control of the constitutive 
GPD1 promoter (plasmid HSP11) compared to cells transformed with a control plasmid (HSP12). Right 
panel: FACS profiles of haploid (RJY358) or diploid (RJY925) wildtype cells and scp160∆ cells (RJY3178) 
with or without Pry3 overexpression. No significant difference is visible between both scp160∆ strains. 
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5. Discussion 
Since the first characterization of Scp160 as an RNA#binding protein (Weber et al., 1997), major 
achievements have been made in the research field of post#transcriptional regulation. Paralleled 
by the optimization of array technologies, sophisticated assays have been developed that target 
the mechanisms by which RBPs control gene expression (Sanchez#Diaz & Penalva, 2006). 
During the last years, a number of different cellular functions have been assigned to Scp160 (see 
chapter 1.6) and large#scale analyses revealed that it binds a large number of transcripts (Hogan et 
al., 2008; Li et al., 2003). However, Scp160's ribosome#associated function – and a large part of 
its cellular pool localizes to polysomes (Lang & Fridovich#Keil, 2000) – still remains elusive.  
In my work, I focused on two main aspects: first, the further characterization of Scp160's binding 
to ribosomes, and second, the identification of mRNAs whose translational activity is dependent 
on Scp160.  
 
5.1. Scp160 binds to ribosomes  
Sucrose density fractionation experiments have demonstrated that Scp160 associates with free 
and membrane#bound polysomes (Frey et al., 2001) as part of a large, RNase#sensitive mRNP 
complex (Lang & Fridovich#Keil, 2000). Whereas fractionation experiments are well#suited to 
determine polysome association of Scp160, affinity purifications may be more precise in 
determining whether its interaction with ribosomes is lost or partially maintained under specific 
conditions. The question whether RNase#treatment of cell extracts disrupts the ribosome 
association of Scp160 completely (Lang & Fridovich#Keil, 2000) or whether a fraction of Scp160 
remains in a complex with 80S ribosomes (Frey et al., 2001) has so far not conclusively been 
answered. In TAP purifications of tagged Scp160, co#purification of 40S and 60S ribosomal 
proteins is in large part RNase#sensitive (Fig. 8). This indicates that an important part of the 
association with ribosomes is mediated indirectly via mRNA and potentially rRNA. A truncated 
version of Scp160 lacking the C#terminal KH domain 14 is compromised in its polysome 
association and was reported to be deficient in the formation of RNPs, as judged from size 
fractionation experiments (Li et al., 2004). Correspondingly, truncation of KH domains 13 and 14 
was reported to disrupt polysome association (Baum et al., 2004). In TAP purifications, in 
contrast, co#purification of ribosomal proteins with Scp160@KH13/14 was only marginally 
decreased (Fig. 10). The disruption of Scp160#mRNP complexes by RNase#treatment (Lang & 
Fridovich#Keil, 2000) and the equivalent effect of a C#terminal truncation (Li et al., 2004) suggest 
that KH13/14 are implicated in RNA binding. This question was directly addressed in this work 
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(see sections 4.6.1. and 4.6.2.). As the C#terminally truncated version of Scp160 still associates 
with ribosomes (Fig. 10), this strengthens the notion that additional factors mediate this 
interaction. In this respect, it should be noted that Scp160 was found to bind ribosomal RNA 
(rRNA) in vitro (Weber et al., 1997), suggesting that direct physical interactions with ribosomal 
components are also involved. Furthermore, Asc1 has been suggested to interact with Scp160 on 
the ribosome. Both proteins bind in close proximity to each other next to the mRNA exit 
channel on the small ribosomal subunit, as demonstrated by chemical crosslinking experiments 
(Baum et al., 2004) and cryo#electron microscopy (Sengupta et al., 2004). In cells lacking Asc1, 
polysome association of Scp160 has been shown to be hampered (Baum et al., 2004). However, I 
have found that in an asc1@ strain, Scp160 still co#purifies with ribosomes to almost the same 
extent as in wildtype cells (Fig. 10). The combined asc1 deletion and truncation of KH13/14 
demonstrated the strongest reduction of ribosome association (Fig. 10). Taken together, affinity 
purifications of Scp160 indicate that its association with ribosomes is based on different, 
cooperating interactions. 
In an attempt to identify new interaction partners of Scp160, prominent bands of TAP#purified 
samples were analyzed by mass spectrometry. Besides ribosomal proteins, the ribosome#
associated proteins Asc1 and Stm1, the RBP Bfr1 and the nascent#chain chaperone Zuo1 were 
found (Fig. 8). Apart from Stm1, these interactors have also been identified in a recent large#scale 
study (Gavin et al., 2006), confirming the specificity of the purification protocol.  
Asc1, the yeast orthologue of mammalian receptor for activated C#kinase (RACK1) (Gerbasi et 
al., 2004), presumably acts as a binding platform for diverse signaling molecules on the ribosome. 
Due to its propeller#like structure of seven WD40 repeats, each of which could potentially 
interact independently with binding partners (Rodriguez et al., 1999), RACK1 is believed to 
integrate inputs from different signaling pathways (Nilsson et al., 2004). For example, RACK1 
recruits activated protein kinase C (PKC) to the ribosome, leading to translation stimulation by 
phosphorylation of eIF6 and subsequent subunit joining (Ceci et al., 2003). As discussed above, 
Scp160 binds to the ribosome in close proximity to Asc1 (Baum et al., 2004). Although my 
results do not confirm the proposed dependency of the Scp160#ribosome interaction on Asc1  
(Fig. 10), the spatial co#localization of both proteins may indicate a functional interaction. 
The Brefeldin A Resistance protein Bfr1, originally suggested to function in the secretory 
pathway (Jackson & Kepes, 1994), has been found to associate with Scp160#containing, 
polysome#associated mRNP complexes (Lang et al., 2001; Sezen et al., 2009; Hogan et al., 2008). 
In line with that, Scp160 is a main co#purifier in Bfr1 immunoprecipitates (Fig. 9). Consistently 
with studies reporting the RNA#dependency of these interactions (Lang et al., 2001; Sezen et al., 
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2009), the Bfr1 signal is completely lost in RNase#treated TAP purifications (Fig. 8). 
Immunofluorescence microscopy showed that both proteins localize to the ER and the outer 
nuclear envelope, which comprises a major part of the yeast ER (Lang et al., 2001). Interestingly, 
loss of Bfr1 has not only been reported to induce abnormal large cells with increased DNA 
content (Jackson & Kepes, 1994) similar to the scp160 knockout, but also to disrupt the 
interaction of Scp160 with polysomes (Lang et al., 2001). Furthermore, a recent extensive 
microarray study of RBP targets has shown that Scp160 and Bfr1 associate with a largely 
overlapping set of mRNAs (Hogan et al., 2008), indicating an intimate functional relationship 
between these two proteins.  
Stm1 has been characterized as a ribosome#associated protein that is important for protein 
synthesis under nutritional stress conditions (Van Dyke et al., 2006). When bound to the 
ribosome, Stm1 may facilitate the release of the ATP#hydrolyzed conformation of eEF3, thereby 
permitting efficient translation elongation (Van Dyke et al., 2009). Interestingly, Scp160 did not 
co#purify with TAP#tagged Stm1 in Coomassie#detectable amounts (Fig. 9), suggesting that most 
Stm1#containing ribosomes are not associated with Scp160, whereas Stm1 is a prominent co#
purifier of Scp160#containing ribosomes. This result is somewhat contradictory to studies 
indicating that Stm1 is present on ribosomes with a close to 1:1 stochiometry (Van Dyke et al., 
2006). However, the same group published results showing that overexpression of Stm1 
enhances its effect on protein synthesis (Van Dyke et al., 2009), a finding that is hard to reconcile 
with endogenous Stm1 being present on every ribosome.  
Zuotin (Zuo1) is a ribosome#associated DnaJ#like chaperone that promotes the folding of 
nascent polypeptide chains as part of the ribosome#associated complex (RAC) (Yan et al., 1998). 
RAC is also involved in the correct sorting of signal#sequence containing nascent polypeptides 
(Wiedmann et al., 1994) and has recently been implicated in cap#independent translation 
(Raychaudhuri et al., 2006), suggesting that it may fulfil additional regulatory functions in addition 
to assisted protein folding.  
Taken together, the finding that Scp160 associates with ribosomes together with other factors 
that have a potentially regulatory function suggests that translation of its target mRNAs is subject 
to complex regulatory mechanisms. 
 
 
 
DISCUSSION 
 - 56 - 
5.2. No evidence for a regulatory subcellular relocalization of Scp160 
Due to its mRNA#binding activity and ribosome association, it has been speculated that Scp160 
positions specific transcripts at the ER, where they are translated (Frey et al., 2001). 
Consequently, Scp160#mediated translational control could involve the modulation of target 
mRNA partitioning between cytosolic and membrane#bound fractions. In spindle pole body 
duplication#defective cells, the Scp160#containing SESA complex has indeed been demonstrated 
to inhibit POM34 mRNA translation by shifting it to the cytosolic fraction (Sezen et al., 2009). If 
this mode of action were generally exerted by Scp160, one would expect to see changes in its 
subcellular localization pattern as soon as a significant fraction of its target mRNAs is 
differentially controlled.  
In accordance with the results from TAP purifications, deletion of asc1 did not induce changes in 
the typical enrichment of Scp160 in the membrane# and ribosome#containing fractions (Fig. 11), 
indicating that an earlier study suggesting the association of Scp160 with polysomes to be 
dependent on Asc1 has to be critically reviewed (Baum et al., 2004). Li and coworkers (2004) 
reported that a truncated version of Scp160 lacking KH domain 14 is compromised for polysome 
association, not competent to form RNPs, and is equally distributed between pellet and soluble 
fractions in differential centrifugation assays. In agreement with these data, I found 
Scp160@KH13/14 to be present in the ribosome#free cytosolic fraction (Fig. 11). However, the 
majority still pelleted with membranes and, to a lesser extent, with membrane#free ribosome#
containing fractions. The same is true for RNA binding#impaired versions of Scp160 carrying 
point mutations in the conserved GXXG motifs of KH domain 14 or KH domains 13/14 (Fig. 
12).  
These findings support the above#stated notion that besides RNA#mediated interactions, 
ribosome association of Scp160 depends on additional factors. Furthermore, it should be noted 
that Scp160 may associate with membranes also independently of ribosomes. For example, 
treatment with EDTA, which disrupts ribosomes, only partially releases Scp160 from the 
membrane fraction (Frey et al., 2001; Weber et al., 1997). In addition, deletion of the last two KH 
domains does not have any significant effect on telomeric silencing, and therefore, given that its 
localization to the nuclear envelope is a prerequisite for Scp160#mediated silencing, the truncated 
version must still sufficiently localize to this membrane compartment (Marsellach et al., 2006). It 
should also be considered that Scp160's co#fractionation with ribosome#containing fractions 
could partially be due to its association with ribosome#free mRNPs of high density. 
Although I could confirm that RNA binding#impaired mutant versions of Scp160 partially 
localize to an additional cytoplasmic pool, I was not able to find a condition under which 
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wildtype Scp160 shows a reproducible shift in its subcellular localization pattern (Figs. 13#16). 
This means that either the cellular answer towards the tested stimuli does not involve Scp160, or 
that the putative Scp160#mediated response does not involve a significant shift in its localization. 
In fact, differential regulation of only a limited number of mRNAs would probably not induce a 
measurable shift of Scp160 itself, as it is the case for the translational regulation of POM34 
mRNA (Sezen et al., 2009).  
 
5.3. Scp160 modulates translation of a specific set of mRNAs 
Scp160's interaction with ribosomes (Figure 8; Lang & Fridovich#Keil, 2000; Baum et al., 2004), 
its association with a plethora of mRNAs (Li et al., 2003; Sezen et al., 2009; Hogan et al., 2008), 
as well as the reduced fitness of scp160#deleted cells and their increased sensitivity against 
translation inhibitors (Figure 6; Baum et al., 2004) strongly suggest that Scp160 is involved in 
translational control. Although this role has been proposed for Scp160 already by several authors 
(Weber et al., 1997; Baum et al., 2004; Frey et al., 2001; Lang & Fridovich#Keil, 2000; 
Mendelsohn et al., 2003), comprehensive studies tackling this question are missing to date. 
Therefore, I followed a systematic approach to identify mRNAs that are translationally controlled 
by Scp160. 
To prevent secondary effects due to ploidy changes in scp160 knock#out cells (Wintersberger et 
al., 1995), I used a Tet#off system (Gari et al., 1997) for the efficient depletion of Scp160 (Fig. 
19). In contrast to other regulatable expression systems such as the GAL cassette (see for 
example Janke et al., 2004), the Tet#off system does not require major changes in the growth 
conditions, but can be shut down simply by the addition of doxycycline to the culture medium. 
In microarray studies, it was shown that doxycycline itself has no significant effect on global gene 
transcription (Wishart et al., 2005), confirming the advantages of this system.  
The translational profiling described here encompassed the analysis of changes at the 
transcriptome level as well as changes in active translation upon depletion of Scp160 (Fig. 20), 
resulting in a comprehensive picture of the influence of Scp160 on transcription, mRNA stability 
and translation.  
At the transcriptome level, depletion of Scp160 affected the abundance of 60 mRNAs, the 
majority of which (82%) showed a decreased level in the absence of Scp160 (Table 1). 
Classification of the proteins encoded by these transcripts demonstrated an enrichment of 
proteins involved in polypeptide folding and stabilization, stress response and energy metabolism 
(Fig. 21), indicating that loss of Scp160 preferentially affects stress#related transcripts. Since 
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doxycycline per se has been reported not to induce any significant changes in the transcriptome 
(Wishart et al., 2005), I suspected that the depletion of Scp160 evokes a general stress response. 
However, this scenario is contradicted by the fact that the identified stress#related mRNAs were 
downregulated upon loss of Scp160, and not, as expected in response to a stress situation, more 
abundant. Since qRT#PCR failed to confirm the microarray results of all mRNAs tested besides 
SCP160 itself (table 1), it is questionable if the apparent effect on stress#related transcripts is real. 
Currently, the discrepancy between microarray and qRT#PCR data cannot be explained, but it 
should be noted that in a related study in which mRNA abundances were measured upon 
depletion of Scp160 by a GAL system, Northern analysis also failed to confirm microarray data 
(Frey, 2002). However, since my microarray results confirmed that YOR338W mRNA levels are 
increased in cells lacking Scp160 (Li et al., 2003), it seems likely that they are only partially 
erroneous and should be in depth validated by qRT#PCR, which was beyond the scope of this 
work.    
Microarray analysis of polysome gradient fractions upon depletion of Scp160 revealed that the 
distribution of 60 mRNAs changed significantly between free mRNPs and polysomes (Table 2). 
Notably, 80% of these mRNAs were shifted towards the heavy gradient fractions, indicating an 
increased polysome load on these mRNAs and a similar function of Scp160 in the regulation of 
these targets. Considering that Scp160 is thought to bind probably more than 1000 mRNAs 
(Hogan et al., 2008), only a very small subset is affected in its ribosome load. However, some 
mRNAs may have been missed due to the activity of residual Scp160. The fact that the vast 
majority of these transcripts shows no significant changes on the transcriptome level 
demonstrates that their differential polysome association is due to regulatory mechanisms other 
than transcription rates and modulation of mRNA stability. Classification of the encoded 
proteins revealed a specific enrichment of cell wall and extracellular proteins as well as proteins of 
the membranous compartment involved in vesicle transport (Fig. 23). These findings are in good 
agreement with a previous large#scale study of Scp160#associated mRNAs, in which Scp160 has 
been found to bind mRNAs encoding proteins of cell wall, plasma membrane, ER and nucleolus 
(Hogan et al., 2008). Most of these transcripts are expected to be translated at the ER, which is 
consistent with the localization of Scp160 to this cellular compartment (Frey et al., 2001). My 
results also fit well into the emerging view of RBPs organizing nascent RNA transcripts into 
functional groups that are coordinately regulated, especially at the level of mRNA stability and 
translation (Keene, 2007). The most striking example for a group of RBPs that bind transcripts 
encoding proteins with common localizations and functions are the five Puf (Pumilio family) 
proteins in yeast: Puf1 and Puf2 preferentially interact with mRNAs encoding membrane#
associated proteins, Puf3 nearly exclusively binds to cytoplasmic mRNAs encoding mitochondrial 
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proteins, Puf4 preferentially associates with transcripts coding for nucleolar ribosomal RNA#
processing factors, and Puf5 binds to mRNAs encoding chromatin modifiers and components of 
the spindle pole body (Gerber et al., 2004). In analogy, it is tempting to speculate that Scp160 
translationally co#regulates its target mRNAs in response to stimuli that affect cell wall and 
membrane#related functions. 
Biochemical analysis of 14 target mRNAs revealed that only four of these mRNAs can be 
demonstrated to co#purify with Scp160, as indicated by qRT#PCR analysis of Scp160 
immunoprecipitates (Table 2, Fig. 24). This again coincides with previous results from Hogan 
and co#workers (Hogan et al., 2008), whose set of Scp160#bound mRNAs includes my verified 
targets and is widely in accordance with my data concerning mRNAs that could not be verified as 
being associated with Scp160. Both results indicate that weaker interaction partners might be lost 
during purification, which is a known drawback of protocols that do not include a cross#linking 
step (Hieronymus & Silver, 2004). Alternatively, mRNAs that were not enriched in the IP#qRT#
PCR assay may not directly associate with Scp160. The observed changes in their translational 
profile might consequently be due to indirect effects caused by translational changes in primary 
(Scp160#bound) target mRNAs.  
Three of the Scp160 target mRNAs tested (AGA1, PRY3 and POM34) were enriched to a similar 
extent in Scp160 and Khd1 immunoprecipitates, whereas enrichment of CCW14 and MSB2 
mRNAs was more pronounced in the case of Scp160 (Fig. 24). Khd1 has originally been 
described as a protein required for efficient localization and translational repression of ASH1 
mRNA (Irie et al., 2002; Hasegawa et al., 2008). However, it has lately been found to bind a set of 
more than 1000 mRNAs (Hasegawa et al., 2008; Hogan et al., 2008). Many of these mRNAs 
encode bud#localized proteins or proteins localized to the cell periphery, like cell wall and cell 
membrane proteins (Hasegawa et al., 2008; Hogan et al., 2008). Thus, Khd1 and Scp160 show 
similar preferences concerning the functional subsets of their RNA targets, which is also reflected 
by the observation that the overlap between the two sets of target mRNAs is significantly higher 
than expected from a random distribution (Hogan et al., 2008). In this regard it is interesting to 
note that Khd1 and Scp160 are two of the three known multi#KH domain containing proteins in 
budding yeast; however, Pbp2, the third member of this group, has been found to interact with 
fewer than ten target mRNAs and therefore likely plays a different role (Hogan et al., 2008). 
Taken together, my results indicate that Scp160 and Khd1 have similar target binding specificities 
and are in good accordance with published data. 
As discussed in section 5.1, the C#terminal KH domains 13 and 14 have been implicated in RNA 
binding. To obtain direct evidence for this assumption, I tested a truncation mutant lacking both 
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KH domains in the IP#qRT#PCR assay and found that it is severely compromised in the binding 
of CCW14, AGA1, PRY3, MSB2 and POM34 mRNAs (Fig. 24). Although I have not tested other 
Scp160#bound mRNAs for their dependence on KH13 and KH14, it is tempting to speculate 
that their binding is also reduced or abolished in the Scp160∆KH13/14 mutant. In order to 
exclude that the RNA binding deficiency of this truncated protein is due to misfolding, I 
additionally tested Scp160 mutants that carry amino acid exchanges in conserved residues of both 
KH domains. As expected, these mutants also showed a strong reduction in target mRNA 
binding (Fig. 25). Corresponding amino acid exchanges in various KH domain#containing 
proteins like Khd1 (Hasegawa et al., 2008), E. coli NusA protein (Zhou et al., 2002) or human 
FMR1 (Siomi et al., 1994) similarly resulted in loss of RNA binding and functional impairment. It 
has been reported that a specific cystein in KH13 (Cys1067) is required for cross#linking Scp160 
to Asc1 (Baum et al., 2004). Therefore, it has been proposed that KH13 and KH14 are involved 
in ribosome binding whereas KH1#12 function in selecting specific mRNAs for targeting to 
ribosomes (Baum et al., 2004). My results designate in contrast that KH13/14 mediate Scp160's 
association with target mRNAs, suggesting that these KH domains fulfil a double function.  
When cells are deprived of Scp160, 60 potential target mRNAs showed significant alterations in 
their abundance in mRNP and polysome fractions, the majority of which shifted towards the 
heavy gradient fractions (see above). In principle, this redistribution would be expected to reflect 
increased association with polysomes and therefore translational upregulation (Melamed et al., 
2009). To test if this applies to PRY3 mRNA, which is one of the transcripts with the most 
pronounced enrichment in the heavy fractions upon depletion of Scp160, I performed 
quantitative Western blotting on epitope#tagged Pry3 protein. Against my expectations, I found 
that Pry3 protein levels are reduced in Scp160#depleted cells (Figs. 26 and 28). This reduction was 
not caused by enhanced degradation, as demonstrated by cycloheximide chase assays (Fig. 29). 
These results indicate that Scp160 does not act as a translational repressor of PRY3 mRNA, but 
in contrast is required for its efficient translation.  
How can the mRNA shift towards the heavy gradient fractions be reconciled with the apparent 
decrease in PRY3 translation? Two scenarios explaining these findings can be envisioned. First, 
the mRNA shift may not result from a differential polysome association of PRY3, but from a 
relocalization of PRY3#translating polysomes from the ER to the cytosol. Second, it is known 
that increased polysome association of an mRNA is not always due to a higher translation rate, 
but can also reflect slower ribosomal transit and therefore less efficient protein synthesis.  
The first scenario is based on the fact that no detergent was used during sample preparation for 
sucrose density centrifugation. Therefore, some of the ER#bound polysomes may have been lost 
DISCUSSION 
 - 61 - 
before application onto the sucrose gradient. If, in the absence of Scp160, PRY3#containing 
polysomes were shifted from the ER membrane to the cytosol, PRY3 mRNA would show an 
apparent enrichment in the heavy fractions. In the cytosol, translation of PRY3 mRNA may be 
blocked by a mechanism which – since affecting polysomes – would have to be different from 
the interaction with signal recognition particles (SRPs). To test if polysome relocalization occurs, 
I used qRT#PCR to determine if PRY3 mRNA is shifted between membrane and cytosolic 
fractions in dependence of Scp160. Preliminary data indicate that no such shift occurs (not 
shown), therefore arguing against the first scenario.  
The second scenario is based on studies demonstrating that under certain conditions, 
translationally inactive polysomes can form. This has for example been described in mitotic cells 
where ribosomal slowdown on bulk mRNA elicits the formation of unusually stable polysomes 
(Kedersha et al., 2005; Sivan et al., 2007). Furthermore, regulation of translation elongation is well 
established upon oxidative stress (Ayala et al., 1996) or treatment with hormones and mitogens 
(Rhoads, 1999). Although the underlying molecular mechanisms are not entirely understood, 
both eEF2 and eEF1 seem to be involved in the regulation of elongation, the latter being of 
specific interest in the context of this study: 
It has been shown that in rabbit, three eEF1 subunits (eEF1A, eEF1Bα, eEF1Bδ) are 
phosphorylated by protein kinase C (PKC) and S6 kinase in vitro or after stimulation, for 
example by insulin (Chang & Traugh, 1998). These modifications enhance elongation by 
stimulating the GDP#to#GTP exchange rate on eEF1A (Peters et al., 1995). In this regard, it is 
interesting to note that Scp160 binds to the ribosome in close proximity to eEF1A and Asc1, the 
yeast homologue of the PKC target RACK1 (Baum et al., 2004; Nilsson et al., 2004). In human 
cells, eEF1A has also been identified to be present in vigilin#containing RNPs, suggesting that 
this interaction may be conserved (Kruse et al., 1998). To determine if Scp160 regulates 
translation elongation through the action of eEF1, it would be interesting to test if its presence 
influences the phosphorylation state of this factor.  
Besides eEF1, the ribosome#associated protein Stm1 is a potential candidate that could be 
involved in Scp160#mediated enhancement of translation elongation. Stm1 is thought to stimulate 
the release of the ADP#bound conformation of eEF3, which enhances elongation efficiency (Van 
Dyke et al., 2009). If Stm1 is absent, polysomes are notably increased due to hampered 
elongation (Van Dyke et al., 2009). Although speculative, the presence of Stm1 on Scp160#
associated ribosomes (see Fig. 8 and section 5.1) could provide a link between Scp160 and 
increased translation elongation. 
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The working hypothesis that Scp160 enhances elongation on its target mRNAs is in good 
accordance with findings indicating that the D. melanogaster Scp160 homologue DDP1 has a 
stimulatory function in the translation of Hsp83 mRNA (see section 2.5.3.; Nelson et al., 2007). 
Although the mechanism of this translational enhancement is unknown – i.e. which step in 
translation is targeted –, the fact that expression of DDP1 fully complements an scp160@ yeast 
strain suggests that both proteins play a similar role in the translation of specific mRNAs. 
 
5.4. A link between translational regulation and ploidy control 
Deletion of Scp160 induces increased ploidy (see section 2.6.1.), suggesting an as yet unclear 
function in the maintenance of the correct DNA content (Wintersberger et al., 1995). In my 
experiments, I identified PRY3 mRNA as a target of Scp160#mediated translational enhancement. 
Most interestingly, I found that downregulation of PRY3 expression induces polyploidization in a 
similar way as deletion of Scp160 (Fig. 30), suggesting a link between translational control exerted 
by Scp160 and polyploidization.  
The function of the cell wall protein Pry3 is largely unknown. Pry3 belongs to the CAP (CRISP#
Ag5#PR) protein superfamily that includes CRISP (cysteine#rich secretory proteins) extracellular 
glycoproteins (Gibbs et al., 2008). The family comprises fungal proteins (including S. cerevisiae 
Pry1#3), mammalian glioma Pr#1 (GLIPR1) proteins, C. elegans LON#1, and plant pathogenesis#
related PR proteins (Gibbs et al., 2008; Morita et al., 2002). Whereas plant PR proteins function 
in systemic acquired resistance against pathogens (Uknes et al., 1992), the function of most other 
members of this family is not clear. It is interesting to note that C. elegans lon#1 mutants exhibit 
an endoreduplication phenotype, resulting in polyploid nuclei of hypodermal tissue (Morita et al., 
2002), which is reminiscent of the increase in ploidy observed in cells with reduced Pry3 levels. 
How the cell wall protein Pry3 is involved in ploidy control remains unknown. C. elegans lon#1 is 
presumably an integral membrane protein and has been proposed to function as an extracellular 
ligand (Morita et al., 2002), suggesting that Pry3 may also be involved in an extracellular signaling 
event. However, the DNA content of cells in which the GPI modification site of Pry3 has been 
removed is almost unchanged (Fig. 27), indicating that Pry3 may have additional functions that 
are independent of its attachment to the cell wall.  
My results indicate that in the absence of Scp160, insufficient translation leads to lower Pry3 
levels, which contributes to the de#regulation of genomic stability or ploidy control. Since 
overexpression of PRY3 from a strong heterologous promoter does not revert the polyploidy 
(4n) phenotype of cells lacking Scp160 (Fig. 31), there might be additional proteins whose 
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translational de#regulation contributes to the genomic instability phenotype of scp160∆ cells. For 
instance, Scp160 has been attributed to function in the SESA network of proteins, which 
regulates translation of a specific set of mRNAs including POM34 (Sezen et al., 2009). The SESA 
network downregulates translation of POM34 and thus rescues mutants with defects in spindle 
pole body duplication (e.g. ndc1#1) and ploidy control (Sezen et al., 2009; Chial et al., 1999).  
However, the function of Scp160 in translational control of specific mRNAs alone cannot 
explain the ploidy phenotype of the deletion strain, since cells expressing a truncated version of 
Scp160 lacking KH domains 13 and 14 have normal FACS profiles (Baum et al., 2004). This 
observation indicates that in addition to RNA binding which is mainly mediated by KH domains 
13 and 14, Scp160 has another function that contributes to ploidy maintenance. Interestingly, 
Scp160@KH13/14 is still fully functional with respect to telomeric silencing (Marsellach et al., 
2006), raising the possibility that Scp160's suggested role in the structural organization of 
heterochromatin is the second key player in Scp160#mediated ploidy control. In this context, it is 
important to note that although a nuclear function of mammalian vigilin and D. melanogaster 
DDP1 in heterochromatin formation and maintenance is well established (see sections 2.5.1. and 
2.5.3.; Zhou et al., 2008; Huertas et al., 2004), it is questionable how far Scp160 acts in the same 
way. For example, it has to date not been possible to show a nuclear localization of full#length 
Scp160 (Brykailo et al., 2007b). Consistently, Scp160 was not found to associate with telomeric 
DNA in ChIP experiments, leading to the hypothesis that it exerts its effect on telomeric 
silencing from its position at the nuclear membrane (Marsellach et al., 2006). It is therefore 
unclear if and how Scp160 directly affects chromosome segregation or other nuclear processes 
that are involved in ploidy maintenance. 
 
Working Model: 
In conjunction with published data, my study supports the following working model. As part of 
large mRNPs containing transcripts destined for translation at the ER, Scp160 localizes to ER 
membranes. My preliminary data indicate that Scp160 is not required for the localization of its 
target mRNAs to the ER, suggesting that it rather co#localizes in a passive manner. At the ER 
membrane, Scp160 enhances translation of its target mRNAs under standard growth conditions, 
probably by stimulating elongation. The regulatory mechanism may involve the action of Asc1, 
eEF1A, and perhaps other protein factors. Upon specific signal cues, Scp160 could differentially 
regulate translation of its target transcripts, which may involve the signal integration capacity of 
Asc1. Defects in translational regulation due to lack of Scp160 presumably contribute to an 
increased cell ploidy phenotype, along with defects in yet#to#be identified functions of Scp160. 
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Fig. 32. Model for translational regulation mediated by Scp160. (A) Scp160 localizes to the ER as 
part of large mRNP complexes containing mRNA, the RBP Bfr1 and the Poly(A)#binding protein Pab1. 
At the ER, Scp160 enhances translation elongation of its target mRNAs. In this process, elongation factor 
eEF1A could be involved as well as the signal integrator Asc1. (B) If cells are deprived of Scp160, target 
mRNAs are still transported to the ER. However, elongation is less efficient, leading to stalled polysomes 
and decreased protein production. 
 
 
In summary, my data substantiate the assumption that Scp160 is involved in translational 
regulation of a specific, functionally related subset of mRNAs. Although results obtained for one 
of the target transcripts suggest a function of Scp160 in enhancement of translational elongation, 
it will be required to test further candidate mRNAs in order to confirm this notion. Furthermore, 
the underlying molecular mechanisms as well as potential regulatory aspects are as yet unknown 
and will be the focus of our future investigations. 
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6. Material and methods 
6.1. Materials 
6.1.1. Consumables and chemicals 
Consumables and chemicals were purchased from the following companies: 
Acros Organics (Geel, Belgium), Applichem (Darmstadt), Applied Biosciences (Darmstadt), 
Apollo Scientific Limited (Bredbury, UK), Axon (Kaiserslautern), Becton Dickinson 
(Heidelberg), Beckman Coulter (Krefeld), Biaffin (Kassel), Biomol (Hamburg), Biorad (Munich), 
Biozym (Hess. Oldendorf), Chemicon (Temecula, Canada), Fermentas (St. Leon#Rot), 
Formedium (Norwich, UK), GE Healthcare (Munich), Gilson (Bad Camberg), Invitrogen 
(Karlsruhe), Macherey & Nagel (Düren), Medac (Hamburg), Medigenomix (Munich), Membra 
Pure (Bodenheim), Merck Biosciences (Darmstadt), Millipore (Molsheim, France), Mobitec 
(Göttingen), MP Biomedical (Illkirch, France), NEB (Frankfurt), Neolab (Heidelberg), Nunc 
(Wiesbaden), Peske (Aindling#Arnhofen), Promega (Mannheim), Qiagen (Hilden), Roche 
(Mannheim), Roth (Karlsruhe), Santa Cruz (Santa Cruz, USA), Sarstedt (Nümbrecht), Semadeni 
(Düsseldorf), Serva (Heidelberg), Sigma (Taufkirchen), Stratagene (Amsterdam, The 
Netherlands), VWR (Ismaning). 
 
6.1.2. Commercially available kits 
Name Supplier 
Colloidal Blue Staining Kit Invitrogen 
QuikChange® SiteDirected Mutagenesis Kit   Stratagene 
QIAquick® Gel Extraction Kit Qiagen 
QIAquick® PCR Purification Kit Qiagen 
QIAprep® Spin Miniprep Kit Qiagen 
CloneJET™ PCR Cloning Kit Fermentas 
Quick Ligation Kit New England Biolabs (NEB) 
High Capacity cDNA Reverse Transcription Kit Applied Biosystems 
Power SYBR® Green PCR Master Mix Applied Biosystems 
NucleoSpin RNA Clean#up Kit Macherey#Nagel 
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6.1.3. Equipment 
Name Supplier 
Research Pipettes P10, P20, P200, P1000 Eppendorf 
Ultracentrifuge L#80; rotor SW40  Beckman Coulter  
RC M120 Ex Micro#Ultracentrifuge; rotor RP120#AT Thermo Fisher Scientific 
T1 Thermal Cycler Biometra 
Sonifier 200 Branson 
Thermomixer Compact Eppendorf 
Cooling centrifuge 5415R Eppendorf 
BioPhotometer Eppendorf 
Tabletop centrifuge Biofuge pico Haereus 
Multifuge 3 L#R Haereus 
Vibrax VXR basic Ika 
Gel documentations system Mitsubishi 
Research PCR cycler PTC#200 MJ 
Akku#Jet Neolab 
Shaking incubator New Brunswick 
Semi#dry blotting device Peqlab 
Universal Analytical balance Sartorius 
Vortex Genie 2 Scientific Industries 
Sorvall Evolution RC; rotors SLC6000, SS#34, SLA#1500 Thermo Fisher Scientific 
Light microscope ICS/KF 2   Zeiss 
Gel electrophoresis chamber Starlab 
FACS Calibur™ flow cytometer Becton Dickinson 
Biocomp Gradient Station Fredericton 
Mini Hybridization Oven MWG Biotech 
Mini#PROTEAN® Tetra Cell   Bio#Rad 
Optimax TR developing machine MS Laborgeräte 
LAS#3000 mini system Fujifilm 
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6.1.4. Enzymes 
Name Supplier 
Taq Polymerase Axon 
CIAP (Calf Intestine Alkaline Phosphatase) Fermentas 
Restriction endonucleases Fermentas 
Quick#T4#DNA#Ligase New England Biolabs (NEB) 
Herculase® II Fusion DNA Polymerase Stratagene 
RNase A Roche 
Zymolyase 20T Seikagaku America 
       
 
6.1.5. Antibodies 
 
 
 
 
Name Source Dilution Company 
Primary Antibodies 
Protein A (PAP) coupled with HRP 1:5000 (Western) Sigma 
Dhh1 rabbit 1:5000 (Western) gift from Karsten Weis 
Sec61 rabbit 1:10000 (Western) gift from Matthias Seedorf 
Asc1 rabbit 1:30000 (Western) gift from Matthias Seedorf 
Rps3 rabbit 1:10000 (Western) gift from Matthias Seedorf 
Rpl4 chicken 1:2000 (Western) gift from Birgitta Beatrix 
Scp160 rabbit 1:30000 (Western) gift from Matthias Seedorf 
myc 9E10 mouse 1:2000 (Western) Evan et al., 1985 
myc 9E11 mouse used for IP Evan et al., 1985 
actin mouse 1:2500 (Western) Chemicon 
Pgk1 mouse 1:10000 (Western) Invitrogen 
    
Secondary antibodies 
anti#mouse#IgG#HRP goat 1:5000 (Western) Dianova 
anti#rabbit#IgG#HRP goat 1:5000 (Western) Dianova 
anti#rat#IgG#HRP goat 1:5000 (Western) Dianova 
anti#chicken#IgY#HRP rabbit 1:5000 (Western) Davids Biotechnologie 
MATERIAL AND METHODS 
 - 68 - 
6.1.6. Oligonucleotides 
In the following list, only oligos used for plasmid generation, site#directed mutagenesis and qRT#
PCR are listed. Oligos used for gene knock#outs, taggings and checking of transformants were 
generated according to standard protocols (Janke et al., 2004; Knop et al., 1999; Gauss et al., 
2005; Puig et al., 2001). 
 
Name 5'3' Sequence 
RJO 2583 CGCAAAGGATCCATGTCTGAAGAACAAACCGC 
RJO 2584 CGCAAACTGCAGCTATCTTCTTAAGGATTTCAAAACC 
RJO 2702 GCTCGATGGAGAATTCAAAATAG 
RJO 2703 CTATTTTGAATTCTCCATCGAGC 
RJO 3200 CAAACGATTCCGCTAAGAAGG 
RJO 3201 CCGGCATATGTAGCAGATGGT 
RJO 3297 CCCAAGCTTATGCTGGAGTTTCCAATATCAG 
RJO 3298 CCCAAGCTTCTAGAAGGCGAACAGAACAGC 
RJO 3332 CAAGGCTTCTTCCACCGAAT 
RJO 3333 GGAAGCTTGCTTGCTCGAAG 
HSO 3 AAAGGACATTGTCGGTGCTG 
HSO 4 AAGCTTCAATAGCGGCTTCG 
HSO 38 TAGGATCCCATTGATCCTTCTTTCTCATTCC 
HSO 39 GCAAGCTTAGTTATGCTTTTCACCGCC 
HSO 46 CGAATCGAGATCTTATCCGGTTCTGCTGCTAGTGGTG 
HSO 47 CAATCGAAGATCTTTAGCTAGTGGATCCGTTCAAG 
HSO 48 TTTTGAAATCCTTAAGAAGACAGATCTAAGCTCTTTGAAACCAATTT 
HSO 49 AAATTGGTTTCAAAGAGCTTAGATCTGTCTTCTTAAGGATTTCAAAA 
HSO 50 GATTCAATATGATTGTTGACCCAGGTGATTCTAACATCAAAAAG 
HSO 51 CTTTTTGATGTTAGAATCACCTGGGTCAACAATCATATTGAATC  
HSO 52 GAATATGTTTCAGAACGTGATGCTTTCAATCAAAAGTTGAGAATG 
HSO 53 CATTCTCAACTTTTGATTGAAAGCATCACGTTCTGAAACATATTC 
  
  
Oligonucleotides for qPCR analyses 
 
Name 5'3' Sequence qPCR target 
RJO 2207 GTGGCTCATTTCAAGCCATT 
RJO 2208 GGACGACCTAGTCGATTCCA ASH1 
RJO 3188 TTGGCCAACGACTTTTATCAGA 
RJO 3189 CGCAATGCTTTTCCGTCTATC CFT1 
RJO 3332 CAAGGCTTCTTCCACCGAAT 
RJO 3333 GGAAGCTTGCTTGCTCGAAG CCW14 
RJO 3330 ACAACCCACTTCTTCCACAGC 
RJO 3331 TCGATTCCACAGAGGTAGATGG AGA1 
RJO 3198 CAAACGAAGGCACCTCTTCC 
RJO 3199 TTGCACCTAGGCTTGTGCTG PRY3 
HSO 29 TGGTCACGGGTTGACAAATAA 
HSO 30 TTCCAACCCAGGGAGTTTTG MSB2 
RJO 3326 CCTGGGGGTAGACATGCAAT 
RJO 3327 TGTGCCATTTGGCTGATCTT POM34 
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HSO 80 AAGGGAAGGAAGGAAAAACGA 
HSO 81 TGTGGACGAGGAAAAAGAATGA HUR1 
RJO 3334 TGATCCCGATACTGGAAATCAA 
RJO 3335 CGAATTTGTATGAAGGGGTGTG HKR1 
HSO 88 CTGCCCTCCCTGGAATACAA 
HSO 89 GGAGTCTGGCTGATGTGTGG SLS1 
HSO 82 GCCCCCAGCACCAGTATTAG 
HSO 83 AGGTTCTCTGCCGATTCCAA PTH1 
RJO 3194 CCACCACCAAGTCCATCTACG 
RJO 3195 GCGTCGATCCACCTGTAGAA VRP1 
RJO 3369 CGCGTCTGAAAATAGCGACA 
RJO 3370 GCCACGAGGCTGTTGAGATA FLO10 
RJO 3328 TCAGCACCAAAGCCAACAAC 
RJO 3329 CCAAGTTGAGGATGCAGCAG FIG2 
RJO 3336 AGAGTCGACCATCCCCAAAG 
RJO 3337 AACATGCTAATCCCTGCATCG DAN4 
RJO 3192 TCCAATCACTGGTGAGCCTTT 
RJO 3193 ATGGGAGAGGATGGTGATGG SEC16 
RJO 3196 GCAACAGCGTTTGCAGATTC 
RJO 3197 TGGCATTGTCTCCTGCACTC NKP2 
HSO 56 TGGCGAAACCAACAAAGAAA 
HSO 57 GGAAGGCGCTTGTAGGTGAG HSP42 
HSO 85 CATTGAAGTCCCAGGTGCAG 
HSO 86 ATCACGGGTACCGGAAGTTG HOR2 
HSO 87 TTCCACCAGGTGAACAGCAG 
HSO 88 GTGTCCTCCGGCTGCAATA LHS1 
HSO 54 TCCGCCTTGGATATGGTACA 
HSO 55 CCCCACTTGTAGGTGGACTTG HSP30 
HSO 89 TTACCCAAAGAGGGCGAATC 
HSO 90 AAGAGCCCAATAGCGACCAA MUP3 
HSO 91 TTCCCATGGCCAATTATTCA 
HSO 92 GCAGCAATCAACCAGCAGAC YRO2 
HSO 58 AGGTACTTCGCCATCCCAGA 
HSO 59 GATCATGGAGTTGGCACCAG HSP104 
HSO 60 ACGGTGAACATGATGCGAAG 
HSO 61 GGCTGCTGAGGCTGGACTAT MGA1 
HSO 93 GGACAGTCCACGAAGCAAAGT 
HSO 94 GCCTTTCCCATAGCCTCCTC TMA10 
HSO 62 GGGCTGCTTTGGCTAAGTTG 
HSO 63 TTGGTGTTCTGGCATTCTGG HSP82 
HSO 64 GAGCTTCACTGGGGTCAAGG 
HSO 65 CCGTTGTGTAAGCGTTCTCG SSE2 
HSO 66 CGATCGTGTACAGGGACGAC 
HSO 67 ATAGTGCTGGGGGATGATGG DCS2 
RJO 3200 CAAACGATTCCGCTAAGAAGG 
RJO 3201 CCGGCATATGTAGCAGATGGT SCP160 
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6.1.7. Plasmids 
Name Short description Reference 
pCM182 pTet CEN TRP Garí et al., 1997 
RJP 1463 pCM182#SCP160 CEN TRP (RJP 1463) This study 
HSP 4 pRS316#prSCP1607SCP160 CEN URA3 This study 
HSP 8 pRS316#prSCP1607SCP160mutKH14myc9 CEN URA3 This study 
HSP 9 pRS316#prSCP1607SCP160myc9 CEN URA3 This study 
HSP 10 pRS316#prSCP1607SCP160mutKH13/14myc9 CEN URA3 This study 
HSP 11 p415#prGPD17PRY3 CEN LEU2 This study 
HSP 12 p415#prGPD1  CEN LEU2 This study 
 
 
The centromeric plasmid pCM182 (Gari et al., 1997) was used to clone wild#type SCP160 under 
the control of the repressible tetracycline operator. The SCP160 ORF was amplified by proof#
reading PCR from vector pMS342 (gift from M. Seedorf) using oligos RJO2583/RJO2584 and 
cloned as BamHI#PstI fragment into pCM182. The resulting plasmid RJP1463 was sequenced 
and confirmed to complement a genomic scp160 deletion in terms of cell ploidy. 
For the generation of plasmids carrying SCP160 variants under control of its own promoter 
pSCP160 (HSP4#HSP10), proof#reading PCR was performed on genomic DNA with primer pair 
HSO38/RJO2702, yielding a fragment encompassing 681 nt of the SCP160 promoter region and 
the first 1836 nt of the SCP160 ORF, and primer pair RJO2703/HSO39, producing a fragment 
spanning the last 1783 nt of the SCP160 ORF and 286 nt of the SCP160 terminator. These PCR 
products were cloned into plasmid pRS426 (Sikorski & Hieter, 1989) using restriction sites 
BamHI/EcoRI and EcoRI/HindIII, respectively, that were either introduced via the PCR oligos 
(HSO38 and HSO39) or naturally present in the SCP160 ORF (EcoRI). To construct plasmid 
HSP4, SCP160 promoter, ORF and terminator were subcloned into pRS316 (Sikorski & Hieter, 
1989) using BamHI/SalI. The introduction of the myc9 tag was done as follows. First, oligos 
HSO46/HSO47 were used with plasmid pYM19 (Janke et al., 2004) to generate a PCR fragment 
containing the myc9 nucleotide sequence flanked by BglII restriction sites. Then, the stop codon 
of SCP160 in HSP4 was conversed to a BglII site by site#directed mutagenesis (HSO48/HSO49) 
(Quik Change II XL Site#Directed Mutagenesis Kit, Stratagene). To generate HSP9, the myc9 
fragment was then introduced in frame after the SCP160 ORF making use of the BglII sites. The 
correct orientation of the insert was confirmed by sequencing. Using HSP9 as template, site#
directed mutageneses were performed to introduce point mutations into the last two KH 
domains of Scp160. By employing oligos HSO50/HSO51, the nucleotide sequence of KH 
domain 14 was altered to exchange both glycines of the GXXG motif by aspartates (G1170D 
and G1173D), giving rise to plasmid HSP8. In addition, with oligos HSO52/HSO53, mutations 
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were introduced into KH domain 13 that induce a replacement of the second glycine of the 
GXXG motif by aspartate (G1028D) and of the conserved isoleucine C#terminal of the GXXG 
motif to asparagine (I1031N), resulting in plasmid HSP10. 
Plasmids HSP11 and HSP12 were constructed as follows. First, the GAL1 promoter of p415 
GAL1 was replaced with the GPD promoter of pYM#N14 making use of the SacI/XbaI 
restriction sites, resulting in HSP12. Then, the PRY3 open reading frame was introduced as 
HindIII fragment that was generated by PCR of genomic DNA using oligos RJO3297 and 
RJO3298, giving HSP11. 
 
6.1.8. Strains 
6.1.8.1. E. coli 
Name Essential Genotype 
TOP10 F
mcrA @(mrr7hsdRMS#mcrBC) φ80lacZ @M15 @lacX74 recA1 araD139 @(ara7leu) 
7697 galU galK rpsL (StrR) endA1 nupG (Invitrogen) 
 
6.1.8.2. S. cerevisiae strains 
All yeast strains that were generated for this work are based on either haploid (RJY 358) or 
diploid (RJY 925) W303 wildtype cells. 
 
Name Essential Genotype 
RJY 358 MATa, ade271, trp171, can17100, leu273,112, his3711,15, ura3, GAL, psi+ 
RJY 925 MATa/MATalpha, ade271, trp171, can17100, leu273,112,  his3711,15, ura3, GAL, psi+ 
RJY 361 MAT a, his1 
RJY 362 MAT alpha, his1 
  
Strains generated in this work: 
RJY 2946 MAT a, SCP1607CBP7TEV7ProtA::K.l.TRP1 
RJY 3000 MAT a, asc1::HIS3MX6 
RJY 3178 MAT a, scp160::HIS3MX6 
RJY 3179 MAT a, STM17CBP7TEV7ProtA::K.l.TRP1 
RJY 3180 MAT a, scp160::HIS3MX6, pCM182SCP160 (RJP 1463) 
RJY 3231 MAT a, SCP1607CBP7TEV7ProtA::K.l.TRP1, asc1::HIS3MX6 
RJY 3256 MAT a, SCP160(KH1712)7CBP7TEV7ProtA::K.l.TRP1 
RJY 3258 MAT a, SCP160(KH1712)7CBP7TEV7ProtA::K.l.TRP1, asc1::HIS3MX6  
RJY 3391 MAT a, BFR17CBP7TEV7ProtA::K.l.TRP1 
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RJY 3487 MAT a, natNT27pGAL17HA37PRY3 
RJY 3498 MAT a, scp160::HIS3MX6, PRY3HA6::natNT2, pCM182SCP160 (RJP 1463) 
RJY 3512 MAT a, SHE2myc9::K.l.TRP1 
RJY 3515 MAT a, SCP160myc9::K.l.TRP1 
RJY 3516 MAT a, SCP160(KH13/14myc9::K.l.TRP1 
HSY 9 MAT a, scp160::HIS3MX6, pRS316prSCP1607SCP160 (HSP 4) 
HSY 10 MAT a, scp160::HIS3MX6, pRS3167prSCP1607SCP160mutKH14myc9 (HSP 8) 
HSY 11 MAT a, scp160::HIS3MX6, pRS3167prSCP1607SCP160myc9 (HSP 9) 
HSY 12 MAT a, scp160::HIS3MX6, pRS316#prSCP1607SCP160mutKH13/14myc9 (HSP 10) 
HSY 14 MAT a pRS314 
HSY 15 MAT a, KHD1myc9::K.l.TRP1 
HSY 19 MAT a, PRY3(GPImyc9::kanMX4 
HSY 20 MAT a, scp160::HIS3MX6, PRY3(GPImyc9::kanMX4 
HSY 21 MAT a, scp160::HIS3MX6, PRY3(GPImyc9::kanMX4, pCM1827SCP160 (RJP 1463) 
 
6.2. Methods 
6.2.1. Standard methods 
Many of the following microbiological and biochemical, as well as molecular biological methods 
such as restriction digests, dephosphorylation of fragments, ligations and separation of DNA in 
agarose gels are based on standard techniques (Ausubel, 2000; Sambrook, 2001). Commercially 
available kits were used according to the manufacturer’s instructions. Point mutations were 
inserted by site directed mutagenesis using the QuickChange® Site#directed Mutagenesis Kit 
(Stratagene). Plasmids were sequenced by Eurofins MWG Operon (www.eurofinsdna.com). For 
all methods described, deionised water was used. 
 
6.2.2. SDSPAGE and Western blotting 
SDS#PAGE was performed according to Laemmli (Laemmli, 1970) using a Mini#PROTEAN® 
Tetra Cell (BioRad). Proteins were transferred onto PVDF membrane using a semi#dry blotting 
device (Peqlab) for 1#2 h at 1.5 mA/cm2. Optimal blotting duration was determined empirically 
and differed with different target proteins (for efficient blotting of Scp160, 2 h were found to be 
required). After transfer, the membrane was blocked with blocking buffer (2% milk#powder in 
PBS containing 0.1% Tween (PBS#T)). Alternatively, membranes were allowed to air#dry and 
stored at 4°C. Reactivation of the PVDF membrane was achieved by incubation with methanol; 
then, membranes were rinsed with water, followed by the normal blocking procedure. Blocked 
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membranes were incubated 1 h to overnight at 4°C with the first antibody diluted in blocking 
buffer. Excess of first antibody was removed by washing the membrane at least three times for 
10 min with PBS#T buffer at RT. Incubation with secondary antibodies diluted 1:5000 in 
blocking buffer was done for 1#2 h at RT. Visualization of immuno#decorated proteins was 
performed using an ECL#Kit (Applichem), followed by exposure of the membrane to light#
sensitive films (GE Healthcare) and subsequent developing using an Optimax TR developing 
machine. Alternatively, signals were detected with an LAS#3000 mini system equipped with a 
CCD camera. Image processing and signal quantification was performed with Image Reader and 
Multi Gauge softwares (Fujifilm).  
 
6.2.3. Yeastspecific techniques 
6.2.3.1. Culture of S. cerevisiae 
Yeast strains were cultured in either full medium (YPD) or synthetic complete (SDC) medium. 
Full medium contained 11 g/l yeast extract, 22 g/l tryptone and 55 mg/l adenine. Synthetic 
complete media contained 6.7 g/l yeast nitrogen base (Formedium), 55 mg/l adenine and 
complete synthetic mix (CSM) as specified by the manufacturer. Media were supplemented with 
2% glucose. For the preparation of solid medium, agar was added at 22 g/l before autoclaving.  
 
6.2.3.2. Dot spots 
Yeast cells from a fresh plate were resuspended in sterile water to OD600 2.0. From this cell 
suspension, six 10#fold dilutions were prepared and 5 Vl were spotted on the respective plates.  
 
6.2.3.3. Transformation of yeast cells 
For high#efficient transformation, competent yeast cells were prepared according to the protocol 
of (Knop et al., 1999). Briefly, 50 ml of the appropriate medium were inoculated to an OD600 of 
0.25 from a dense overnight culture of the respective strain and grown at 30°C to an OD600 of 
0.5#0.7. Cells were harvested by centrifugation (4000 g, 5 min), washed once with 25 ml sterile 
water and once with 5 ml LitSorb (0.1 M lithium acetate, 10 mM Tris/HCl pH 8.0, 1 mM EDTA, 
1 M sorbitol; pH 8.0). The cell pellet was then resuspended in 360 Vl LitSorb and 40 Vl of salmon 
sperm DNA (heated for 5 min at 95°C and rapidly cooled on ice) was added. After gentle mixing, 
50 Vl aliquots were directly stored at #80°C. For transformation with PCR fragments, 20 Vl of 
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purified PCR product and 420 Vl of LitPEG (0.1 M lithium acetate, 10 mM Tris/HCl pH 8.0,  
1 mM EDTA, 40% (w/v) PEG 3350; pH 8.0) were added to one aliquot of competent cells and 
incubated at RT for 30 min. 54 Vl of DMSO were added and samples were put to 42°C for  
15 min, before cells were spun down and plated on adequate selective medium. Cells transformed 
with fragments containing the kanMX marker were allowed to recover for 3 h at 30°C in YEPD 
before plating.  
Plasmids were introduced by a one#step transformation protocol. One inoculation loop of cells 
were scraped from a fresh plate, washed with sterile water and resuspended in 100 Vl of one#step 
buffer (0.2 M lithium acetate, 40% (w/v) PEG 3350, 100 mM DTT). 10 Vl 2 mg/ml salmon 
sperm DNA and 100#500 ng plasmid DNA were added and samples were incubated at 45°C for 
30 min. Then, cells were pelleted by centrifugation and plated on selective medium. 
 
6.2.3.4. Knockout and tagging of yeast genes 
The chromosomal deletion of yeast genes as well as the C# or N#terminal insertion of epitope 
tags were performed by a PCR#based strategy (Janke et al., 2004; Knop et al., 1999; Gauss et al., 
2005). The introduction of C#terminal TAP tags was carried out as described elsewhere (Puig et 
al., 2001). Briefly, PCR products were generated from special cassette modules that consist of a 
selection marker and, for tagging applications, an additional sequence encoding the tag. The PCR 
primers used for this purpose contain sequences homologous to the respective tagging cassette, 
allowing for efficient amplification of the module, as well as sequences homologous to the 
flanking regions of the genomic target site. PCR products were purified using the QIAquick® 
PCR Purification Kit (Qiagen) and used for transformation of competent yeast cells. 
Transformants were analyzed for correct integration of the module by colony PCR; epitope 
tagging was in addition confirmed by Western Blot analysis of whole cell extracts. 
N#terminal epitope taggings were performed so that the target genes were put back under their 
own promoters (Gauss et al., 2005). This is achieved by using marker cassettes that are flanked by 
loxP sites which are recognized by Cre recombinase. Upon expression of Cre recombinase from 
a galactose#inducible vector (pSH47), the marker cassette is excised via recombination and the 
expression of the target gene from its own promoter is restored.  
Gene deletions and taggings were checked by PCR using oligos annealing in the respective 
marker cassette and in the UTR or coding region of the gene. 
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6.2.4. Preparation of nucleic acids and cell extracts 
6.2.4.1. Preparation of RNA 
For the preparation of RNA, at least 4 OD600 of cells were harvested by centrifugation, 
resuspended in 1 ml cold TE buffer, and transferred to 2 ml safe#lock Eppendorf tubes. After a 
short spin and removal of the supernatant, the cell pellet was resuspended in 500 Vl Cross RNA 
buffer I (stored at 4°C). 200 Vl of acid#washed glass beads and 400 Vl of 
Phenol/Chloroform/Isoamyl alcohol (25:24:1, Roth) were added, followed by 10 min vigorous 
shaking of the samples at 4°C. Samples were spun for 5 min at 13.000 rpm and 4°C and 400 Vl of 
supernatant were transferred to a fresh Eppendorf cup. Precipitation of the RNA was achieved 
by addition of 1 ml 96% ethanol and at least 20 min incubation at #20°C, upon which the RNA 
was pelleted by centrifugation (20 min, 13.000 rpm, 4°C). Pellets were washed with 70% ethanol, 
dried and resuspended in 84 Vl DEPC#treated water. For digestion of genomic DNA, 10 Vl of 
DNase buffer, 4 Vl of RQ DNase, and 2 Vl of RNasin (all from Promega) were added and the 
reactions were incubated at 37°C for 15 min. For standard applications (e.g. qPCR), samples were 
extracted again with Phenol/Chloroform/Isoamyl alcohol and RNA was precipitated from the 
aqueous phase by addition of 1/10 volume 3 M sodium acetate, pH 5.2, and 3 volumes 96% 
ethanol. To prepare highly pure RNA for microarray analysis, DNase#treated samples were 
purified using a spin column#based cleanup kit (NucleoSpin RNA Clean#up, Macherey#Nagel) 
according to the manufacturer's directions. 
 
6.2.4.2. Preparation of DNA 
Genomic DNA was prepared from 10 ml of dense overnight cultures. Cells were harvested by 
centrifugation, washed once with water and resuspended in 200 Vl of breaking buffer (2% Triton 
X#100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0). 200 Vl of acid#
washed glass beads (425#600 Vm diameter; Sigma) and 200 Vl phenol/chloroform/isoamyl 
alcohol (24:24:1 v/v/v; Roth) were added and the samples were vortexed vigorously for 4 min. 
Then, 400 Vl of TE buffer was added followed by centrifugation for 5 min at 13.000 rpm and 
4°C. The aqueous phase was transferred to a new tube and DNA was precipitated by addition of 
1 ml 96% ethanol and centrifugation for 5 min. The pellet was washed once with 70% ethanol, 
dried at 37°C (4 min) and resuspended in 200 Vl water. To remove RNA, samples were incubated 
with 7 Vl RNase A (Roche) at 37°C for 15 min. Samples were then supplemented with 20 Vl 3 M 
sodium acetate, pH 5.2, and 500 Vl ethanol. DNA was pelleted by centrifugation (5 min, 13.000  
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rpm, 4°C) and washed as before. After resuspension in 50 Vl water, the quality of the purified 
DNA was monitored by agarose gel electrophesis. 
 
6.2.4.3. Alkaline lysis 
Protein samples for Western blotting, e.g. to check for successful integration of epitope tags or 
for efficient depletion of Scp160, were prepared by alkaline lysis. 2#10 OD600 of cells, alternatively 
one inoculation loop full of cells scraped from a fresh plate, were resuspended in 1 ml of water. 
Cell lysis was achieved by addition of 150 Vl of a solution containing 1.85 M NaOH and 7.5%  
ß#mercaptoethanol, followed by 15 min incubation on ice. Proteins were then precipitated by 
adding 150 Vl of 50% trichloracetic acid and incubating 10 min on ice. Then, proteins were 
pelleted by centrifugation (15 min, 13000 rpm, 4°C) and resuspended in 50 Vl Laemmli buffer. To 
ensure complete denaturation, samples were heated for 10 min at 65°C.  
 
6.2.4.4. Preparation of native whole cell extracts 
Protein samples in which epitope#tagged Pry3 protein variants were to be detected by Western 
blotting were prepared by native instead of alkaline cell lysis since this method yielded clearer 
Pry3 signals. 20 OD600 of logarithmically growing cells were harvested by centrifugation, washed 
once with water and resuspended in 500 Vl of low#salt buffer (20 mM Hepes#KOH pH 7.6, 100 
mM potassium acetate, 5 mM magnesium acetate, 1 mM EDTA, 2 mM DTT, 0.5 mM PMSF and 
0.25 mM benzamidine) and vortexed for 5 min with 400 Vl glass beads. After centrifugation  
(2 min, 100 × g), the supernatant was collected, Laemmli buffer was added and samples were 
incubated at 65°C for 10 min. 
 
6.2.5. Sucrose density gradients 
6.2.5.1. Sucrose density gradient fractionation 
Whole cell extracts for fractionation experiments were prepared as follows. To 180 ml of 
logarithmically growing cells, CHX was added to a final concentration of  
0.1 mg/ml and incubated for 10 min at 30°C on a shaking platform. Cells were harvested and the 
pellet was resuspended in 400 Vl polysome buffer (20 mM HEPES/KOH pH 7.5, 75 mM KCl, 
2.5 mM MgCl2, 1 mM EGTA, 0.1 mg/ml CHX, 1 mM DTT) supplemented with 2.5 Vl 
SUPERase#In (Ambion). 200 Vl of glass beads were added and the samples were vortexed 
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vigorously for 5 min at 4°C. After centrifugation (5 min, 16000 × g, 4°C), the supernatant was 
collected, snap#frozen and stored at #80°C until use.  
Extract corresponding to 600 Vg of RNA was loaded onto a 12 ml 20#60% linear sucrose 
gradient in polysome buffer and centrifuged for 2 h at 155000 × g  and 4°C in an SW40 rotor. 
750 Vl fractions were collected from top to bottom using a Biocomp Gradient Station 
(Fredericton) with continous UV absorption measurement at 256 nm. 
 
6.2.5.2. RNA purification from gradient fractions 
For the preparation of RNA for microarray analyses, gradient fractions containing mRNPs, 
ribosomal subunits and monosomes (light fractions) and fractions containing three or more 
polysomes (heavy fractions) were pooled. Then, the samples were phenol#chloroform extracted, 
and RNA was precipitated with isopropanol from the 1:4 diluted aqueous phase. Pellets were 
washed once with 70% ethanol, dried at 37°C and redissolved in 154 Vl water (total volume per 
sample pool). 
For digestion of genomic DNA, 10 Vl DNase buffer, 10 Vl RQ1 DNase, and 4 Vl RNasin (all 
from Promega) were added and the reactions were incubated at 37°C for 25 min. DNase#treated 
samples were purified using a spin column#based cleanup kit (NucleoSpin RNA Clean#up, 
Macherey#Nagel) according to the manufacturer's directions. Samples were snap#frozen and 
stored at #80°C until further use. RNA integrity was monitored by running 1 Vg of RNA on a 1% 
agarose TAE gel and staining with ethidium bromide.  
 
6.2.6. Subcellular fractionation 
Subcellular fractionation experiments were performed as described elsewhere (Frey et al., 2001). 
180 ml cultures were grown to OD600 0.5#0.6 and CHX was added to a final concentration of  
100 Vg/ml. Cells were harvested by centrifugation and washed once with water containing  
100 Vg/ml CHX. Pellets were resuspended in 1 ml of ice#cold low#salt buffer (20 mM Hepes#
KOH pH 7.6, 100 mM KAc, 5 mM Mg acetate, 1 mM EDTA, 2 mM DTT, 100 Vg/ml CHX,  
0.5 mM PMSF and 0.25 mM benzamidine) and vibraxed with 400 Vl glass beads at top speed for 
5 min at 4°C. Cell debris was pelleted by centrifugation (2 min, 1200 rpm) and the supernatant 
(whole cell extract, WCE) was transferred to a new tube. These lysates were fractionated by 
consecutive centrifugation steps at 6000 (pellet P6), 18000 (pellet P18) and 200000 g (pellet P200, 
supernatant S200) for 20 min at 4°C. After each centrifugation step, pellets were rinsed twice 
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with ice#cold water and resuspended in 100#150 Vl low#salt buffer. For Western blot analysis, 
Laemmli buffer was added to the respective samples. RNA was extracted by vortexing with an 
equivalent volume of Phenol/Chloroform/Isoamyl alcohol (25:24:1, Roth). After 5 min 
centrifugation at 13000 rpm, RNA was precipitated from the aqueous phase by incubation with 
1/10 Vol 3 M sodium acetate pH 5.2 and 3 Vol 96% ethanol. Upon centrifugation (30 min, 
13000 rpm), the pellet was washed with 70% ethanol, dried at 37°C and resuspended in DEPC#
treated water. DNase treatment was carried out as described in section 6.2.5.2. 
 
6.2.7. Tetoff depletion system 
Plasmid RJP1463, used to control SCP160 expression by the repressible tetracycline operator 
(Gari et al., 1997), was generated as described in section 6.1.7. SCP160 expression in  scp160@ 
strains complemented with RJP1463 was shut down by addition of 2 Vg/ml doxycycline to the 
respective growth medium. Depletion efficiencies were tested by Western analysis of time course 
samples. 
 
6.2.8. FACS analysis 
For FACS analysis, 2 OD600 units of logarithmically growing cells were harvested, washed twice 
with 50 mM Tris/HCl pH 8.0 and resuspended in the same buffer containing 70% ethanol. 
Samples were incubated at least 1 h up to several days at 4°C, before 100 Vl of the suspension 
was spun down, washed twice with 50 mM Tris/HCl pH 8.0 and resuspended in the same buffer 
supplemented with 2 mg/ml RNaseA (Roche). Upon incubation at 50°C for 2 h on a turning 
wheel, Proteinase K (Roche) was added to a final concentration of 0.8 mg/ml and samples were 
incubated for additional 60 min at 50°C. Cells were pelleted by centrifugation, washed twice with 
FACS buffer (200 mM Tris/HCl pH 7.5, 211 mM NaCl, 78 mM MgCl2) and taken up in 500 Vl 
FACS#PI buffer (180 mM Tris/HCl pH 7.5, 190 mM NaCl, 70 mM MgCl2, 50 Vg/ml propidium 
iodide). Samples were then incubated in the dark for 1#2 h on a turning wheel. Prior to analysis, 
samples were briefly sonicated in a water bath and diluted 1:4 in 50 mM Tris/HCl pH 8.0 buffer.  
Samples were analyzed in a FACS Calibur™ flow cytometer (Becton Dickinson) fitted with an 
argon laser (15 mW, 488 nm). Propidium iodide fluorescence was detected in the FL2 channel 
(585/42 nm). 20000 events were observed for each sample. Data collection was performed using 
CellQuest™ software (Becton Dickinson), and data analysis was carried out with WinMDI 
version 2.8, provided by Joseph Trotter (Scripps Research Institute, La Jolla, CA). 
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6.2.9. Microarray analysis 
6.2.9.1. Sample preparation and microarray hybridization 
RNA samples for microarray analysis were prepared as described in sections 6.2.4.1. (preparation 
of total RNA) and 6.2.5.2. (preparation of RNA from gradient fractions). All subsequent steps 
were conducted by the Kompetenzzentrum für Fluoreszente Bioanalytik, Regensburg 
(http://www.kfb#regensburg.de). Quality and quantity of the RNA were determined using an 
Agilent 2100 bioanalyzer (Agilent Technologies). For the preparation of biotinylated probes, the 
MessageAmp II Biotin Enhanced Kit (Ambion) was used. Biological sample duplicates were 
hybridized to Affymetrix Yeast Genome 2.0 Arrays. 
 
6.2.9.2. Microarray data analysis 
Raw signal intensities for each probe in the .CEL files were analyzed using version 6.4 of the 
PARTEK GENOMICS SUITE software (Partek Inc.). Data were filtered by application of an 
expanded mask file that was based on the s_cerevisiae.msk file of Affymetrix, to mask the  
S. pombe probe sets, unspecific probe sets, and replicate probe sets of S. cerevisiae. The robust 
multiarray average (RMA) normalization method was used for background correction (Irizarry et 
al., 2003), quantile normalization and medianpolish probe set summerization.  
For the analysis of total RNA, the final gene list was filtered with a p#value cut#off of 0.05 and a 
fold change threshold of ≥2.5 or ≤0.4. Genes listed as “dubious open reading frames (ORFs)” in 
the Saccharomyces Genome Database (SGD) were removed. 
For the arrays that were hybridized with samples from gradient fractions, a principal component 
analysis (PCA) revealed a batch effect due to different scanning days. This effect was removed by 
the batch effect removal tool implemented in the PARTEK software package. In a first step, the 
translational state (= mRNA abundance in heavy versus light fractions) was calculated for all 
mRNAs in control and Scp160 depleted cells. This was done with one#way analysis of variance 
(ANOVA) applying a linear contrast to compare heavy (“H”) with baseline light (“L”) samples. 
In a second step, the translational state change was calculated for all mRNAs as follows: 
(Hdox/Ldox) / (Hwt/Lwt). The translational state of mRNAs of Scp160 depleted cells were 
compared to baseline control cells. Genes listed as “dubious open reading frames (ORFs)” in the 
Saccharomyces Genome Database (SGD) were removed. The final gene list was further filtered 
by a translational state change cut#off value of ≥1.8 or ≤0.56 in order to reveal mRNAs with 
stronger shifts in their translation efficiency.       
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6.2.9.3. Systematic classification of proteins 
For systematic classification of significantly over#represented biological processes and subcellular 
localizations, gene lists were analyzed on the basis of the MIPS Functional Catalogue Database 
(FunCatDB) (Ruepp et al., 2004).  
 
6.2.10. Quantitative realtime PCR (qPCR) 
Quantitative RT#PCR (qRT#PCR) was performed using the StepOnePlus™ Real#Time PCR 
System (Applied Biosystems). Reaction mixtures (10 Vl final volume) contained 2.5 Vl of 1:8 
dilutions of the individual cDNA samples, 5 pmol forward and reverse primers (see section 
6.1.6.) and Power SYBR® Green PCR Master Mix (Applied Biosystems) as prescribed by the 
manufacturer. Primers were designed using Primer3 software version 0.4.0 
(http://frodo.wi.mit.edu/primer3/input.htm) and tested for mispriming or formation of primer#
dimers by melting curve analysis of the individual amplification products. The thermocycling 
profile included an initial denaturation for 10 min at 95°C, followed by 35 cycles of amplification, 
comprising denaturation at 95°C for 15 sec and annealing/elongation at 60°C for 1 min. After 
each cycle, a single fluorescence measurement was taken. For melting curve analysis of the 
amplification products, the temperature was increased in 0.3°C fractions to a final temperature of 
95°C (continuous fluorescence measurement). All reactions were run in duplicates and included a 
negative control (H2O). Relative quantifications were performed by the comparative CT method 
(Livak & Schmittgen, 2001). 
 
6.2.11. Immunoprecipitation 
6.2.11.1. Covalent coupling of αmyc antibody to Protein G beads   
For immunoprecipitation experiments, monoclonal mouse αmyc antibody 9E11 (Evan et al., 
1985) was coupled to magnetic Dynabeads® Protein G (Invitrogen Dynal). 1 ml beads slurry was 
washed twice with 1 ml 0.1 M sodium phosphate pH 7.0 and divided into four samples. To each 
sample, 1.25 ml hybridoma supernatant was added and incubated for 40 min at RT on a wheel. 
Beads were then washed twice with 1 ml 0.1 M sodium phosphate pH 7.0 and twice with 1 ml  
0.2 M triethanolamin pH 8.2, pooled and incubated for 30 min at RT in 1 ml 20 mM dimethyl 
pimelimidate in 0.2 M triethanolamin on a wheel. The supernatant was removed and replaced by 
1 ml 50 mM Tris/HCl pH 7.5. After 15 min incubation, beads were washed as follows: 
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3× in 1 ml 1× PBS/0.1% Tween 
2× in 1 ml 1× TBS pH 7.4 
1× in 1 ml 0.1 M Glycine/HCl pH 2.5 
2× in 1 ml 0.1 M Tris/HCl pH 8.8 
2× in 1 ml 1× TBS pH 7.4 
Then, beads were taken up in 1 ml of the last buffer (50% slurry) and stored at 4°C. 
 
6.2.11.2. Immunoprecipitation and preparation of RNA 
Immunoprecipitation of C#terminally myc9#tagged Scp160 variants, She2 and Khd1 was carried 
out essentially as described previously (Bohl et al., 2000). 30 OD600 units of logarithmically 
growing cells were harvested and resuspended in 200 Vl breaking buffer (50 mM HEPES/KOH 
pH 7.3, 20 mM potassium acetate, 2 mM EDTA pH 8.0, 0.1% Triton X#100, 5% glycerol, 0.8 
U/Vl RNasin, 0.5 mM PMSF, 0.25 mM benzamidine). Glass bead lysis was performed by 
vortexing vigorously four times for 3 min with 1 min pause on ice between the cycles. 100 Vl of 
breaking buffer was added and samples were centrifuged for 2 min at 0.8 × g. The supernatant 
(T, total extract) was added to Protein G magnetic beads coupled to anti myc antibody (see 
section 6.4.11.1) (blocked three times for 10 min in breaking buffer containing 0.1 mg/ml tRNA) 
and incubated for 1 h 15 min on a turning wheel at 4°C. Then, the flowthrough (FT) was 
removed and beads were washed three times with wash buffer (50 mM Hepes/KOH, 50 mM 
KOAc, 2 mM magnesium acetate, 0.1% Triton X#100, 5% glycerol). One#third of the beads was 
resuspended in SDS#PAGE loading buffer for Western analysis (IP). RNA bound to the 
remaining beads was extracted with phenol#chloroform, ethanol precipitated, resuspended in 
RQ1 DNase buffer, and treated with RQ1 DNase (Promega). For reverse transcription, the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) was used with random 
hexamers as primers and 250 ng RNA input per 20 Vl reaction.  
 
6.2.12. Tandem Affinity Purification (TAP) 
6.2.12.1. Cell culture and lysis 
For TAP purifications, cultures were grown in 2 l YEPD medium to OD600 3.5#4.0. Cells were 
harvested by centrifugation, washed once with water and resuspended in once cell volume  
(10#15 ml) cold TAP buffer (100 mM NaCl, 50 mM Tris/HCl pH 7.5, 1.5 mM MgCl2, 0.15% 
NP#40) containing 1 mM DTT, 0.5 mM PMSF and 0.25 mM benzamidine. Two cell volumes of 
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acid#washed glass beads were added, and cells were lysed in a bead mill (Fritsch) using the 
following milling protocol: 3 x [4 min, 500 rpm, 2 min break]. To remove glass beads and cell 
debris, lysates were passed through a 50 ml syringe and centrifuged for 10 min at 4000 rpm and 
4°C. For preclearing, the extract was subsequently spun for 30 min at 20000 g and 4°C in an SS#
34 rotor. The fatty top phase was removed by aspiration, the cleared extract was collected, 
supplemented with glycerol to a final concentration of 5% and snap#frozen in liquid nitrogen.  
 
6.2.12.2. Purification and TCA precipitation 
400 Vl IgG Sepharose beads (Amersham Biosciences) were washed three times with cold TAP 
buffer supplemented with 1 mM DTT and added to the cell lysate. After 1 h incubation on a 
turning wheel at 4°C, beads were pelleted and transferred to a Mobicol spin column (MoBiTec). 
Using a syringe and gravity flow, beads were washed with 10 ml TAP buffer containing 0.5 mM 
DTT. For purifications of Scp160, IgG beads were washed with 20 ml of the same buffer and the 
second purification step (binding to calmodulin beads) was omitted. To cleave off specifically 
bound protein complexes, 10 Vl TEV protease were added in 150 Vl TAP#buffer plus 0.5 mM 
DTT and incubated for 1 h 20 min on a turning wheel at 16°C. For elution, the column was 
centrifuged in a table top centrifuge for 1 min at 2000 rpm. 
During TEV cleavage, 250 Vl calmodulin affinity resin (Stratagene) was washed three times with 
TAP buffer containing 1 mM DTT and 2 mM CaCl2, once with the same buffer plus 4 mM 
CaCl2, and transferred with 150 Vl of the last buffer to a new Mobicol column. TEV cleaved 
material was eluted from the first column by centrifugation (1 min, 2000 rpm, 4°C) and added to 
the washed calmodulin beads. After 1 h rotation at 4°C, beads were washed with 5 ml TAP 
buffer supplemented with 2 mM CaCl2. 600 Vl of elution buffer (10 mM Tris/HCl pH 8.0, 5 mM 
EDTA, pH 8.0) was added and the samples were incubated for 10 min at 37°C while shaking 
with 600 rpm. The eluate was collected by centrifugation (1 min, 2000 rpm) and proteins were 
precipitated with trichloracetic acid (10% final concentration). To identify interaction partners of 
the TAP#tagged protein, samples were run on an SDS#PAGE gel; bands of interest were excised 
and send for mass spec analysis to the protein analysis unit of the university (ZfP; 
http://proteinanalytik.web.med.uni#muenchen.de).
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7. Abbreviations 
 
aa      amino acid 
Amp      ampicillin 
ATP      adenosine triphosphate 
bp      basepair 
°C      degree centigrade 
C. elegans     Caenorhabditis elegans 
CHX     cycloheximide 
CIP      calf intestine phospatase 
clonNAT     nourseothricin 
CSM      complete supplement mix 
C#terminal    carboxy terminal 
kDa      kilo dalton 
D. melanogaster   Drosophila melanogaster 
DEPC     diethylpyrocarbonate 
DNA      deoxyribonucleic acid 
DNase     deoxyribonuclease 
dNTP      deoxyribonucleosid triphosphate 
DTT      dithiothreitol 
dox     doxycycline 
ECL      enhanced chemoluminiscence 
E. coli      Escherichia coli 
EDTA     ethylenediaminotetraacetic acid 
eEF     eukaryotic elongation factor 
eIF     eukaryotic initiation factor 
ER      endoplasmic reticulum 
et al.      et alii (from Latin, “and others”) 
g      gram 
x g      relative centrifugal force (rcf) 
G. gallus    Gallus gallus 
GEF     guanine nucleotide exchange factor 
h      hour 
H. sapiens    Homo sapiens 
HA      hemagglutinin 
Hepes      4#(2#hydroxyethyl)#1#piperazineethanesulfonic acid 
k      kilo 
kb      kilo basepairs 
KH#domain     heterogeneous nuclear (hn)RNP K#homology domain 
l      litre 
LB      Luria Bertani 
V      micro 
m      milli 
M      molar 
mA      milliampere 
min      minutes 
mRNA     messenger ribonucleic acid 
n      nano 
NES     nuclear export sequence 
NLS     nuclear localization sequence 
NP#40      Nonidet P#40 (Igepal#CA#630) 
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NTP      nucleoside triphosphate 
nt      nucleotide 
OD      optical density 
ORF      open reading frame 
PAGE     polyacrylamide gelelectrophoresis 
PBS      phosphate#buffered saline 
PCR      polymerase chain reaction 
PEG      polyethylene glycol 
pH      potential of hydrogen 
Pi     pyrophosphate 
RNA      ribonucleic acid 
RBD     RNA#binding domain 
RBP      RNA#binding protein 
RNP      ribonucleoprotein 
rpm      revolutions per minute 
RT      room temperature 
S. cerevisiae     Saccharomyces cerevisiae 
SDS      sodium dodecyl sulfate 
s      second 
S      sedimentation coefficient (Svedberg) 
TAP     tandem affinity purification 
TCA     trichloroacetic acid 
tet     tetracycline 
TEV     tobacco etch virus 
Tris      trishydroxymethylaminomethane 
tRNA      transfer ribonucleic acid 
UTR      untranslated region 
V      volt 
WCE      whole cell extract 
wt      wild type 
X. laevis    Xenopus laevis 
YEP      yeast extract peptone 
YNB      yeast nitrogen base 
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Schreck H, Mayer A, Cramer P, Jansen R#P (2010) Translational control by the yeast multi#KH 
domain protein Scp160 contributes to control of ploidy. Nucleic Acids Res (submitted) 
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